Viewing Study NCT04632992

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 3:58 PM

Ignite Modification Date: 2026-02-25 @ 8:49 PM

Study NCT ID: NCT04632992

Status: COMPLETED

Last Update Posted: 2025-01-08

First Post: 2020-11-12

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: A Study Evaluating Targeted Therapies in Participants Who Have Advanced Solid Tumors With Genomic Alterations or Protein Expression Patterns Predictive of Response

Sponsor:

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Raw JSON

{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24', 'submissionTracking': {'firstMcpInfo': {'postDateStruct': {'date': '2024-12-06', 'type': 'ACTUAL'}}}}, 'interventionBrowseModule': {'meshes': [{'id': 'C000607349', 'term': 'entrectinib'}, {'id': 'C000723546', 'term': 'inavolisib'}, {'id': 'C582670', 'term': 'alectinib'}, {'id': 'C583616', 'term': 'ipatasertib'}, {'id': 'C000594389', 'term': 'atezolizumab'}, {'id': 'D000080044', 'term': 'Ado-Trastuzumab Emtansine'}, {'id': 'C485206', 'term': 'pertuzumab'}, {'id': 'D000068878', 'term': 'Trastuzumab'}, {'id': 'C000705452', 'term': 'tucatinib'}, {'id': 'D017239', 'term': 'Paclitaxel'}, {'id': 'C000730814', 'term': 'Tiragolumab'}, {'id': 'C000655704', 'term': 'pralsetinib'}], 'ancestors': [{'id': 'D008453', 'term': 'Maytansine'}, {'id': 'D018942', 'term': 'Macrolides'}, {'id': 'D007783', 'term': 'Lactones'}, {'id': 'D009930', 'term': 'Organic Chemicals'}, {'id': 'D047029', 'term': 'Lactams, Macrocyclic'}, {'id': 'D047028', 'term': 'Macrocyclic Compounds'}, {'id': 'D011083', 'term': 'Polycyclic Compounds'}, {'id': 'D061067', 'term': 'Antibodies, Monoclonal, Humanized'}, {'id': 'D000911', 'term': 'Antibodies, Monoclonal'}, {'id': 'D000906', 'term': 'Antibodies'}, {'id': 'D007136', 'term': 'Immunoglobulins'}, {'id': 'D007162', 'term': 'Immunoproteins'}, {'id': 'D001798', 'term': 'Blood Proteins'}, {'id': 'D011506', 'term': 'Proteins'}, {'id': 'D000602', 'term': 'Amino Acids, Peptides, and Proteins'}, {'id': 'D012712', 'term': 'Serum Globulins'}, {'id': 'D005916', 'term': 'Globulins'}, {'id': 'D043823', 'term': 'Taxoids'}, {'id': 'D043822', 'term': 'Cyclodecanes'}, {'id': 'D003516', 'term': 'Cycloparaffins'}, {'id': 'D006840', 'term': 'Hydrocarbons, Alicyclic'}, {'id': 'D006844', 'term': 'Hydrocarbons, Cyclic'}, {'id': 'D006838', 'term': 'Hydrocarbons'}, {'id': 'D004224', 'term': 'Diterpenes'}, {'id': 'D013729', 'term': 'Terpenes'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'genentech@druginfo.com', 'phone': '800 821-8590', 'title': 'Medical Communications', 'organization': 'Hoffmann-La Roche'}, 'certainAgreement': {'otherDetails': "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.", 'restrictionType': 'OTHER', 'piSponsorEmployee': False, 'restrictiveAgreement': True}}, 'adverseEventsModule': {'timeFrame': 'From initiation of study drug until 28 days after the final dose of study drugs other than atezolizumab and until 90 days after the final dose of atezolizumab (Up to 32 months)', 'description': 'Safety evaluable population included all participants who received at least one dose of the study drug.', 'eventGroups': [{'id': 'EG000', 'title': 'Arm B: Inavolisib (GDC-0077)', 'description': 'Participants with a positive tumor biomarker result for PIK3CA activating mutation self-administered inavolisib 9 mg, orally, QD until disease progression, intolerable toxicity, or consent withdrawal whichever occurs first.', 'otherNumAtRisk': 26, 'deathsNumAtRisk': 26, 'otherNumAffected': 25, 'seriousNumAtRisk': 26, 'deathsNumAffected': 19, 'seriousNumAffected': 5}, {'id': 'EG001', 'title': 'Arm C: Alectinib', 'description': 'Participants with a positive tumor biomarker result for ALK gene fusion self-administered alectinib, 600 mg, orally, BID until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.', 'otherNumAtRisk': 5, 'deathsNumAtRisk': 5, 'otherNumAffected': 5, 'seriousNumAtRisk': 5, 'deathsNumAffected': 1, 'seriousNumAffected': 2}, {'id': 'EG002', 'title': 'Arm D: Ipatasertib', 'description': 'Participants with a positive tumor biomarker result for phosphatase and tensin homolog (PTEN) loss/loss-of-function or protein kinase B (AKT) activating mutation self-administered ipatasertib, 400 mg orally, QD until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.', 'otherNumAtRisk': 26, 'deathsNumAtRisk': 26, 'otherNumAffected': 25, 'seriousNumAtRisk': 26, 'deathsNumAffected': 16, 'seriousNumAffected': 6}, {'id': 'EG003', 'title': 'Arm E: Atezolizumab + Chemotherapy', 'description': 'Participants with a positive tumor biomarker result for TMB-H or MSI-H or dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle in combination with investigators choice of chemotherapy (docetaxel, paclitaxel, or capecitabine) until disease progression, loss of clinical benefit, or unacceptable toxicity whichever occurs first.', 'otherNumAtRisk': 25, 'deathsNumAtRisk': 25, 'otherNumAffected': 25, 'seriousNumAtRisk': 25, 'deathsNumAffected': 16, 'seriousNumAffected': 11}, {'id': 'EG004', 'title': 'Arm F: Trastuzumab Emtansine + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for human epidermal growth factor receptor 2 (HER2) gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by trastuzumab emtansine, 3.6 milligrams/kilograms (mg/kg), as IV infusion, every 21 days until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.', 'otherNumAtRisk': 25, 'deathsNumAtRisk': 25, 'otherNumAffected': 23, 'seriousNumAtRisk': 25, 'deathsNumAffected': 16, 'seriousNumAffected': 9}, {'id': 'EG005', 'title': 'Arm G: PH FDC SC', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received PH FDC SC, a loading dose of 1200 mg pertuzumab + 600 mg trastuzumab as subcutaneous (SC) injection on Day 1 of Cycle 1 followed by a maintenance dose of 600 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of each 21-day cycle, starting at Cycle 2.', 'otherNumAtRisk': 13, 'deathsNumAtRisk': 13, 'otherNumAffected': 11, 'seriousNumAtRisk': 13, 'deathsNumAffected': 6, 'seriousNumAffected': 2}, {'id': 'EG006', 'title': 'Arm H: PH FDC SC + Chemotherapy', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received PH FDC SC, a loading dose of 1200 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of Cycle 1 followed by a maintenance dose of 600 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of each 21-day cycle, starting at Cycle 2 in combination with investigators choice of chemotherapy (docetaxel, paclitaxel, or capecitabine).', 'otherNumAtRisk': 8, 'deathsNumAtRisk': 8, 'otherNumAffected': 8, 'seriousNumAtRisk': 8, 'deathsNumAffected': 8, 'seriousNumAffected': 2}, {'id': 'EG007', 'title': 'Arm I: Trastuzumab Emtansine + Tucatinib', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received trastuzumab emtansine, 3.6 mg/kg as IV infusion, every 21 days in combination with tucatinib, 300 mg, orally, BID starting from Cycle 1 Day 1 until disease progression or unacceptable toxicity, whichever occurs first.', 'otherNumAtRisk': 23, 'deathsNumAtRisk': 23, 'otherNumAffected': 23, 'seriousNumAtRisk': 23, 'deathsNumAffected': 14, 'seriousNumAffected': 6}, {'id': 'EG008', 'title': 'Arm J: Trastuzumab Emtansine + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation plus TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by trastuzumab emtansine, 3.6 mg/kg, as IV infusion, every 21 days until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.', 'otherNumAtRisk': 19, 'deathsNumAtRisk': 19, 'otherNumAffected': 19, 'seriousNumAtRisk': 19, 'deathsNumAffected': 16, 'seriousNumAffected': 7}, {'id': 'EG009', 'title': 'Arm K: Ipatasertib + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for PIK3CA activating mutation received ipatasertib, 400 mg, orally QD in combination with atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.', 'otherNumAtRisk': 28, 'deathsNumAtRisk': 28, 'otherNumAffected': 26, 'seriousNumAtRisk': 28, 'deathsNumAffected': 22, 'seriousNumAffected': 10}, {'id': 'EG010', 'title': 'Arm L: Ipatasertib + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for PTEN loss/loss-of-function or AKT-activating mutation self-administered ipatasertib, 400 mg, orally, QD and received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or intolerable toxicity, whichever occurs first.', 'otherNumAtRisk': 25, 'deathsNumAtRisk': 25, 'otherNumAffected': 25, 'seriousNumAtRisk': 25, 'deathsNumAffected': 10, 'seriousNumAffected': 8}, {'id': 'EG011', 'title': 'Arm M: Ipatasertib + Paclitaxel', 'description': 'Participants with a positive tumor biomarker result for co-mutations in PIK3CA activating mutations and PTEN loss/loss-of-function or AKT-activating mutation self-administered ipatasertib, 400 mg, orally, QD on Days 1 to 21 of 28-day cycles and received paclitaxel, 80 mg/m\\^2, as IV infusion on Days 1, 8, and 15 of each 28-day cycle until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.', 'otherNumAtRisk': 3, 'deathsNumAtRisk': 3, 'otherNumAffected': 3, 'seriousNumAtRisk': 3, 'deathsNumAffected': 2, 'seriousNumAffected': 2}, {'id': 'EG012', 'title': 'Arm N: Atezolizumab + Tiragolumab', 'description': 'Participants with a positive tumor biomarker result for TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by tiragolumab, 600 mg, as IV infusion on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.', 'otherNumAtRisk': 23, 'deathsNumAtRisk': 23, 'otherNumAffected': 21, 'seriousNumAtRisk': 23, 'deathsNumAffected': 10, 'seriousNumAffected': 6}, {'id': 'EG013', 'title': 'Arm O: Pralsetinib', 'description': 'Participants with a positive tumor biomarker result for RET gene fusion self-administered pralsetinib, 400 mg, orally, QD until disease progression, intolerable toxicity, or consent withdrawal whichever occurs first.', 'otherNumAtRisk': 3, 'deathsNumAtRisk': 3, 'otherNumAffected': 3, 'seriousNumAtRisk': 3, 'deathsNumAffected': 1, 'seriousNumAffected': 2}], 'otherEvents': [{'term': 'Anaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 4, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 7, 'numAffected': 5}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 5, 'numAffected': 5}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 7, 'numAffected': 5}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 7, 'numAffected': 6}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 3, 'numAffected': 2}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Leukocytosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Thrombocytopenia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 4, 'numAffected': 3}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Thrombocytosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Atrial fibrillation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Sinus tachycardia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Tachycardia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Hypothyroidism', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Endocrine disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Dry eye', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Eye disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Lacrimation increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 5, 'numAffected': 4}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Eye disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Periorbital oedema', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Eye disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Vision blurred', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Eye disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Visual impairment', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Eye disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Abdominal distension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Abdominal hernia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Abdominal pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 7, 'numAffected': 6}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Abdominal pain upper', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Anal incontinence', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Ascites', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 4, 'numAffected': 2}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Constipation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 6, 'numAffected': 4}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 6, 'numAffected': 4}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 6, 'numAffected': 6}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 5, 'numAffected': 4}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 4, 'numAffected': 3}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 9, 'numAffected': 7}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Dental caries', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Diarrhoea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 7, 'numAffected': 6}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 35, 'numAffected': 19}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 20, 'numAffected': 16}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 5, 'numAffected': 5}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 13, 'numAffected': 8}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 30, 'numAffected': 18}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 23, 'numAffected': 18}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 7, 'numAffected': 3}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 6, 'numAffected': 4}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 3, 'numAffected': 2}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Dry mouth', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 5, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Dyspepsia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Dysphagia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Flatulence', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Gastrooesophageal reflux disease', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 5, 'numAffected': 5}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Haematochezia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Haemorrhoidal haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Haemorrhoids', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Nausea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 8, 'numAffected': 7}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 15, 'numAffected': 13}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 10, 'numAffected': 8}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 6, 'numAffected': 6}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 15, 'numAffected': 11}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 6, 'numAffected': 6}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 16, 'numAffected': 13}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 11, 'numAffected': 11}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 5, 'numAffected': 3}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 11, 'numAffected': 10}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Oesophagitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Rectal haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Stomatitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 8, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Vomiting', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 9, 'numAffected': 6}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 8, 'numAffected': 7}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 10, 'numAffected': 9}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 7, 'numAffected': 6}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Asthenia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Chills', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Fatigue', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 9, 'numAffected': 9}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 7, 'numAffected': 5}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 17, 'numAffected': 13}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 17, 'numAffected': 13}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 13, 'numAffected': 12}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 9, 'numAffected': 8}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 11, 'numAffected': 9}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 13, 'numAffected': 12}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 4, 'numAffected': 3}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 6, 'numAffected': 6}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Gait disturbance', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Influenza like illness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Injection site reaction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 4, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Localised oedema', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Mass', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Non-cardiac chest pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Oedema', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Oedema peripheral', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 4, 'numAffected': 3}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 4, 'numAffected': 3}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Performance status decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Peripheral swelling', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 6, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Pyrexia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 5, 'numAffected': 3}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 5, 'numAffected': 4}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'COVID-19', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Candida infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Cellulitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Colonic abscess', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Cystitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Diverticulitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Herpes zoster', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Otitis media', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Penile infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Pneumonia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Respiratory tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Sinusitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Skin infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Tinea infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Upper respiratory tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Urinary tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 6, 'numAffected': 4}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Accidental overdose', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 5, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 5, 'numAffected': 2}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Contusion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Fall', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 5, 'numAffected': 4}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Incorrect dose administered', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Infusion related reaction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 7, 'numAffected': 6}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Injection related reaction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Limb injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Muscle strain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Overdose', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 5, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Post procedural haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Rib fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Spinal fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Underdose', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 5, 'numAffected': 4}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Vascular access complication', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Alanine aminotransferase increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 5, 'numAffected': 5}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 10, 'numAffected': 6}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Aspartate aminotransferase increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 4, 'numAffected': 3}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 9, 'numAffected': 7}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 22, 'numAffected': 11}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 4, 'numAffected': 2}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 4, 'numAffected': 3}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Blood albumin decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Blood alkaline phosphatase increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 5, 'numAffected': 3}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Blood bicarbonate decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Blood bilirubin increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 3, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 3, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Blood creatinine decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Blood creatinine increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 6, 'numAffected': 3}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Blood glucose increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Blood iron decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Cardiac murmur', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Ejection fraction decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Lymphocyte count decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Neutrophil count decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Neutrophil count increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Occult blood', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Platelet count decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 6, 'numAffected': 4}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Weight decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 5, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Weight increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Decreased appetite', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 6, 'numAffected': 6}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 6, 'numAffected': 6}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 8, 'numAffected': 7}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 11, 'numAffected': 9}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Dehydration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 6, 'numAffected': 5}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 9, 'numAffected': 8}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 5, 'numAffected': 5}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 7, 'numAffected': 6}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 10, 'numAffected': 9}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 4, 'numAffected': 2}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 12, 'numAffected': 6}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Hyperglycaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 17, 'numAffected': 12}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 5, 'numAffected': 5}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 5, 'numAffected': 5}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 6, 'numAffected': 6}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Hypoalbuminaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Hypoglycaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Hypokalaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 4, 'numAffected': 3}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 1}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Hypomagnesaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Hyponatraemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 4, 'numAffected': 2}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Hypovolaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Iron deficiency', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Obesity', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Arthralgia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 6, 'numAffected': 5}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 5, 'numAffected': 3}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 4, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Back pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 4, 'numAffected': 3}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Bone pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Muscle spasms', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Muscular weakness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 6, 'numAffected': 5}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 3, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Musculoskeletal chest pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Myalgia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 6, 'numAffected': 4}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Neck pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Pain in extremity', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 4, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Cancer pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Brain oedema', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Cognitive disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Dizziness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Dysgeusia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 6, 'numAffected': 6}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Headache', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Hypoaesthesia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Memory impairment', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Neuralgia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Neuropathy peripheral', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Paraesthesia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Peripheral sensory neuropathy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Syncope', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Toxic encephalopathy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Tremor', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Anxiety', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Confusional state', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Depression', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Insomnia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Acute kidney injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Dysuria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Haematuria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 5, 'numAffected': 4}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Micturition urgency', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Pollakiuria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Proteinuria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Urinary retention', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Pelvic pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Vaginal cyst', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Aphonia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Cough', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 9, 'numAffected': 4}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 4, 'numAffected': 3}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 4, 'numAffected': 3}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Dysphonia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Dyspnoea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 4, 'numAffected': 3}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Epistaxis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 4, 'numAffected': 3}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Hypoxia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Oropharyngeal pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Pleural effusion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Pneumonitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Productive cough', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Rhinitis allergic', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Rhinorrhoea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Wheezing', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Alopecia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Cold sweat', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Decubitus ulcer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Dermatitis acneiform', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Dry skin', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Hyperhidrosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Nail disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Onychoclasis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Palmar-plantar erythrodysaesthesia syndrome', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 7, 'numAffected': 6}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Pruritus', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 8, 'numAffected': 7}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Rash', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 5, 'numAffected': 3}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Rash maculo-papular', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 5, 'numAffected': 4}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 5, 'numAffected': 4}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 9, 'numAffected': 7}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 8, 'numAffected': 6}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Skin fissures', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Skin hyperpigmentation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Skin ulcer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Skin weeping', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Flushing', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Hot flush', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Hypertension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Hypotension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 4, 'numAffected': 4}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 3, 'numAffected': 2}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}], 'seriousEvents': [{'term': 'Anaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Febrile neutropenia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Thrombocytopenia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Atrial fibrillation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Cardiac arrest', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Myocardial infarction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Supraventricular tachycardia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Abdominal distension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Abdominal pain upper', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Ascites', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Colitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Diarrhoea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Enteritis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Gastritis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Gastrointestinal fistula', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Gastrointestinal haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Nausea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 3, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Rectal haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Small intestinal obstruction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Vomiting', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Asthenia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Chest pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Fatigue', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Pyrexia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Acute hepatic failure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Abdominal infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'COVID-19', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Cellulitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Clostridium difficile infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Colonic abscess', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 3, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Coronavirus infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Gangrene', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Oesophageal candidiasis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Oral candidiasis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Perirectal abscess', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Peritonitis bacterial', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Pneumonia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Pyelonephritis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Sepsis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Septic shock', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Urinary tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Urosepsis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Wound infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Fall', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Femur fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Infusion related reaction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Platelet count decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Dehydration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Failure to thrive', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Hypercalcaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Hyperglycaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Hypokalaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Hypomagnesaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Back pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Haemarthrosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Muscular weakness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Spinal stenosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Brain oedema', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Cerebrovascular accident', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Embolic stroke', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Hypoaesthesia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Paraesthesia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Seizure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Device breakage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Product Issues', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Device malfunction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Product Issues', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Device occlusion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Product Issues', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Confusional state', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Mental status changes', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Acute kidney injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Haematuria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Urinary retention', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Urinary tract obstruction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Acute respiratory failure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Aspiration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Chronic obstructive pulmonary disease', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Dyspnoea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Pneumonitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Pneumothorax', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Arterial haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}, {'term': 'Peripheral vascular disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 5, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 26, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 25, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 13, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG008', 'numAtRisk': 19, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG009', 'numAtRisk': 28, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG010', 'numAtRisk': 25, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG011', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG012', 'numAtRisk': 23, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG013', 'numAtRisk': 3, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 26.1'}], 'frequencyThreshold': '5'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'Confirmed Objective Response Rate (ORR) Assessed by Investigator According to Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1) or Response Assessment in Neuro-Oncology (RANO) Criteria for Primary Central Nervous System (CNS) Tumors', 'denoms': [{'units': 'Participants', 'counts': [{'value': '26', 'groupId': 'OG000'}, {'value': '5', 'groupId': 'OG001'}, {'value': '26', 'groupId': 'OG002'}, {'value': '25', 'groupId': 'OG003'}, {'value': '25', 'groupId': 'OG004'}, {'value': '13', 'groupId': 'OG005'}, {'value': '8', 'groupId': 'OG006'}, {'value': '23', 'groupId': 'OG007'}, {'value': '19', 'groupId': 'OG008'}, {'value': '28', 'groupId': 'OG009'}, {'value': '25', 'groupId': 'OG010'}, {'value': '3', 'groupId': 'OG011'}, {'value': '23', 'groupId': 'OG012'}, {'value': '3', 'groupId': 'OG013'}]}], 'groups': [{'id': 'OG000', 'title': 'Arm B: Inavolisib (GDC-0077)', 'description': 'Participants with a positive tumor biomarker result for PIK3CA activating mutation self-administered inavolisib 9 mg, orally, QD until disease progression, intolerable toxicity, or consent withdrawal whichever occurs first.'}, {'id': 'OG001', 'title': 'Arm C: Alectinib', 'description': 'Participants with a positive tumor biomarker result for ALK gene fusion self-administered alectinib, 600 mg, orally, BID until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'OG002', 'title': 'Arm D: Ipatasertib', 'description': 'Participants with a positive tumor biomarker result for phosphatase and tensin homolog (PTEN) loss/loss-of-function or protein kinase B (AKT) activating mutation self-administered ipatasertib, 400 mg orally, QD until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'OG003', 'title': 'Arm E: Atezolizumab + Chemotherapy', 'description': 'Participants with a positive tumor biomarker result for TMB-H or MSI-H or dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle in combination with investigators choice of chemotherapy (docetaxel, paclitaxel, or capecitabine) until disease progression, loss of clinical benefit, or unacceptable toxicity whichever occurs first.'}, {'id': 'OG004', 'title': 'Arm F: Trastuzumab Emtansine + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for human epidermal growth factor receptor 2 (HER2) gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by trastuzumab emtansine, 3.6 milligrams/kilograms (mg/kg), as IV infusion, every 21 days until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG005', 'title': 'Arm G: PH FDC SC', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received PH FDC SC, a loading dose of 1200 mg pertuzumab + 600 mg trastuzumab as subcutaneous (SC) injection on Day 1 of Cycle 1 followed by a maintenance dose of 600 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of each 21-day cycle, starting at Cycle 2.'}, {'id': 'OG006', 'title': 'Arm H: PH FDC SC + Chemotherapy', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received PH FDC SC, a loading dose of 1200 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of Cycle 1 followed by a maintenance dose of 600 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of each 21-day cycle, starting at Cycle 2 in combination with investigators choice of chemotherapy (docetaxel, paclitaxel, or capecitabine).'}, {'id': 'OG007', 'title': 'Arm I: Trastuzumab Emtansine + Tucatinib', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received trastuzumab emtansine, 3.6 mg/kg as IV infusion, every 21 days in combination with tucatinib, 300 mg, orally, BID starting from Cycle 1 Day 1 until disease progression or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG008', 'title': 'Arm J: Trastuzumab Emtansine + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation plus TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by trastuzumab emtansine, 3.6 mg/kg, as IV infusion, every 21 days until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG009', 'title': 'Arm K: Ipatasertib + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for PIK3CA activating mutation received ipatasertib, 400 mg, orally QD in combination with atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG010', 'title': 'Arm L: Ipatasertib + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for PTEN loss/loss-of-function or AKT-activating mutation self-administered ipatasertib, 400 mg, orally, QD and received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or intolerable toxicity, whichever occurs first.'}, {'id': 'OG011', 'title': 'Arm M: Ipatasertib + Paclitaxel', 'description': 'Participants with a positive tumor biomarker result for co-mutations in PIK3CA activating mutations and PTEN loss/loss-of-function or AKT-activating mutation self-administered ipatasertib, 400 mg, orally, QD on Days 1 to 21 of 28-day cycles and received paclitaxel, 80 mg/m\\^2, as IV infusion on Days 1, 8, and 15 of each 28-day cycle until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'OG012', 'title': 'Arm N: Atezolizumab + Tiragolumab', 'description': 'Participants with a positive tumor biomarker result for TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by tiragolumab, 600 mg, as IV infusion on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG013', 'title': 'Arm O: Pralsetinib', 'description': 'Participants with a positive tumor biomarker result for RET gene fusion self-administered pralsetinib, 400 mg, orally, QD until disease progression, intolerable toxicity, or consent withdrawal whichever occurs first.'}], 'classes': [{'categories': [{'measurements': [{'value': '11.5', 'groupId': 'OG000', 'lowerLimit': '2.4', 'upperLimit': '30.2'}, {'value': '20.0', 'groupId': 'OG001', 'lowerLimit': '0.5', 'upperLimit': '71.6'}, {'value': '11.5', 'groupId': 'OG002', 'lowerLimit': '2.4', 'upperLimit': '30.2'}, {'value': '28.0', 'groupId': 'OG003', 'lowerLimit': '12.1', 'upperLimit': '49.4'}, {'value': '12.0', 'groupId': 'OG004', 'lowerLimit': '2.5', 'upperLimit': '31.2'}, {'value': '0.0', 'groupId': 'OG005', 'lowerLimit': '0.0', 'upperLimit': '24.7'}, {'value': '0.0', 'groupId': 'OG006', 'lowerLimit': '0.0', 'upperLimit': '36.9'}, {'value': '13.0', 'groupId': 'OG007', 'lowerLimit': '2.8', 'upperLimit': '33.6'}, {'value': '0.0', 'groupId': 'OG008', 'lowerLimit': '0.0', 'upperLimit': '17.6'}, {'value': '0.0', 'groupId': 'OG009', 'lowerLimit': '0.0', 'upperLimit': '12.3'}, {'value': '0.0', 'groupId': 'OG010', 'lowerLimit': '0.0', 'upperLimit': '13.7'}, {'value': '66.7', 'groupId': 'OG011', 'lowerLimit': '9.4', 'upperLimit': '99.2'}, {'value': '21.7', 'groupId': 'OG012', 'lowerLimit': '7.5', 'upperLimit': '43.7'}, {'value': '33.3', 'groupId': 'OG013', 'lowerLimit': '0.8', 'upperLimit': '90.6'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Up to 32 months', 'description': 'Confirmed objective response rate (cORR)=percentage of participants with best response as complete response (CR) or partial response (PR) for measurable disease \\& CR for non-measurable disease. Confirmation=CR/PR on 2 consecutive visits ≥4 weeks apart for 3-week cycles \\& ≥6 weeks apart for 4-week cycles. Per RECIST, CR=disappearance of all target lesions. PR= ≥30% decrease in sum of diameters of target lesions, in absence of CR. Per RANO, CR=complete disappearance of all measurable \\& non-measurable disease for ≥4 weeks; no new lesions/abnormality on T2/FLAIR imaging; stable/improved non-enhancing lesions; participants must be off corticosteroids or on physiological doses; clinical status stable/improved. PR= ≥50% decrease in the sum of products of perpendicular diameters of measurable enhancing lesions on T2/FLAIR imaging for ≥4 weeks; no progression of non-measurable T1 disease; stable/improved non-enhancing lesions; corticosteroid dose ≤ baseline; clinical status stable/improved.', 'unitOfMeasure': 'percentage of participants', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'Efficacy population included all participants who received at least one dose of study treatment and either had at least one post-baseline tumor assessment or discontinued treatment for any reason. Percentages have been rounded off to the nearest decimal point.'}, {'type': 'SECONDARY', 'title': 'Progression-Free Survival (PFS) as Determined by the Investigator According to RECIST v1.1 or RANO Criteria', 'denoms': [{'units': 'Participants', 'counts': [{'value': '26', 'groupId': 'OG000'}, {'value': '5', 'groupId': 'OG001'}, {'value': '26', 'groupId': 'OG002'}, {'value': '25', 'groupId': 'OG003'}, {'value': '25', 'groupId': 'OG004'}, {'value': '13', 'groupId': 'OG005'}, {'value': '8', 'groupId': 'OG006'}, {'value': '23', 'groupId': 'OG007'}, {'value': '19', 'groupId': 'OG008'}, {'value': '28', 'groupId': 'OG009'}, {'value': '25', 'groupId': 'OG010'}, {'value': '3', 'groupId': 'OG011'}, {'value': '23', 'groupId': 'OG012'}, {'value': '3', 'groupId': 'OG013'}]}], 'groups': [{'id': 'OG000', 'title': 'Arm B: Inavolisib (GDC-0077)', 'description': 'Participants with a positive tumor biomarker result for PIK3CA activating mutation self-administered inavolisib 9 mg, orally, QD until disease progression, intolerable toxicity, or consent withdrawal whichever occurs first.'}, {'id': 'OG001', 'title': 'Arm C: Alectinib', 'description': 'Participants with a positive tumor biomarker result for ALK gene fusion self-administered alectinib, 600 mg, orally, BID until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'OG002', 'title': 'Arm D: Ipatasertib', 'description': 'Participants with a positive tumor biomarker result for phosphatase and tensin homolog (PTEN) loss/loss-of-function or protein kinase B (AKT) activating mutation self-administered ipatasertib, 400 mg orally, QD until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'OG003', 'title': 'Arm E: Atezolizumab + Chemotherapy', 'description': 'Participants with a positive tumor biomarker result for TMB-H or MSI-H or dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle in combination with investigators choice of chemotherapy (docetaxel, paclitaxel, or capecitabine) until disease progression, loss of clinical benefit, or unacceptable toxicity whichever occurs first.'}, {'id': 'OG004', 'title': 'Arm F: Trastuzumab Emtansine + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for human epidermal growth factor receptor 2 (HER2) gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by trastuzumab emtansine, 3.6 milligrams/kilograms (mg/kg), as IV infusion, every 21 days until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG005', 'title': 'Arm G: PH FDC SC', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received PH FDC SC, a loading dose of 1200 mg pertuzumab + 600 mg trastuzumab as subcutaneous (SC) injection on Day 1 of Cycle 1 followed by a maintenance dose of 600 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of each 21-day cycle, starting at Cycle 2.'}, {'id': 'OG006', 'title': 'Arm H: PH FDC SC + Chemotherapy', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received PH FDC SC, a loading dose of 1200 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of Cycle 1 followed by a maintenance dose of 600 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of each 21-day cycle, starting at Cycle 2 in combination with investigators choice of chemotherapy (docetaxel, paclitaxel, or capecitabine).'}, {'id': 'OG007', 'title': 'Arm I: Trastuzumab Emtansine + Tucatinib', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received trastuzumab emtansine, 3.6 mg/kg as IV infusion, every 21 days in combination with tucatinib, 300 mg, orally, BID starting from Cycle 1 Day 1 until disease progression or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG008', 'title': 'Arm J: Trastuzumab Emtansine + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation plus TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by trastuzumab emtansine, 3.6 mg/kg, as IV infusion, every 21 days until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG009', 'title': 'Arm K: Ipatasertib + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for PIK3CA activating mutation received ipatasertib, 400 mg, orally QD in combination with atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG010', 'title': 'Arm L: Ipatasertib + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for PTEN loss/loss-of-function or AKT-activating mutation self-administered ipatasertib, 400 mg, orally, QD and received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or intolerable toxicity, whichever occurs first.'}, {'id': 'OG011', 'title': 'Arm M: Ipatasertib + Paclitaxel', 'description': 'Participants with a positive tumor biomarker result for co-mutations in PIK3CA activating mutations and PTEN loss/loss-of-function or AKT-activating mutation self-administered ipatasertib, 400 mg, orally, QD on Days 1 to 21 of 28-day cycles and received paclitaxel, 80 mg/m\\^2, as IV infusion on Days 1, 8, and 15 of each 28-day cycle until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'OG012', 'title': 'Arm N: Atezolizumab + Tiragolumab', 'description': 'Participants with a positive tumor biomarker result for TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by tiragolumab, 600 mg, as IV infusion on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG013', 'title': 'Arm O: Pralsetinib', 'description': 'Participants with a positive tumor biomarker result for RET gene fusion self-administered pralsetinib, 400 mg, orally, QD until disease progression, intolerable toxicity, or consent withdrawal whichever occurs first.'}], 'classes': [{'categories': [{'measurements': [{'value': '4.24', 'groupId': 'OG000', 'lowerLimit': '1.84', 'upperLimit': '8.08'}, {'value': '4.98', 'comment': 'The upper limit of the 95% confidence interval (CI) was not estimable because there was an insufficient number of events.', 'groupId': 'OG001', 'lowerLimit': '1.54', 'upperLimit': 'NA'}, {'value': '3.48', 'groupId': 'OG002', 'lowerLimit': '1.87', 'upperLimit': '6.47'}, {'value': '3.94', 'groupId': 'OG003', 'lowerLimit': '2.17', 'upperLimit': '8.38'}, {'value': '4.73', 'groupId': 'OG004', 'lowerLimit': '2.07', 'upperLimit': '10.22'}, {'value': '2.46', 'groupId': 'OG005', 'lowerLimit': '1.77', 'upperLimit': '5.16'}, {'value': '3.02', 'groupId': 'OG006', 'lowerLimit': '1.54', 'upperLimit': '5.52'}, {'value': '2.69', 'groupId': 'OG007', 'lowerLimit': '1.94', 'upperLimit': '6.18'}, {'value': '1.87', 'groupId': 'OG008', 'lowerLimit': '1.71', 'upperLimit': '2.20'}, {'value': '2.10', 'groupId': 'OG009', 'lowerLimit': '1.64', 'upperLimit': '3.48'}, {'value': '3.61', 'groupId': 'OG010', 'lowerLimit': '2.33', 'upperLimit': '6.34'}, {'value': '5.98', 'comment': 'The upper limit of the 95% CI was not estimable because there was an insufficient number of events.', 'groupId': 'OG011', 'lowerLimit': '1.28', 'upperLimit': 'NA'}, {'value': '4.76', 'groupId': 'OG012', 'lowerLimit': '1.87', 'upperLimit': '16.43'}, {'value': '7.10', 'comment': 'The upper limit of the 95% CI was not estimable because there was an insufficient number of events.', 'groupId': 'OG013', 'lowerLimit': '1.84', 'upperLimit': 'NA'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'Time from start of treatment to the first occurrence of disease progression or death from any cause (Up to 32 months)', 'description': 'PFS=time from start of treatment to the first occurrence of disease progression (PD) or death from any cause, whichever occurs first, per RECIST v1.1, or RANO. Per RECIST, PD=≥20% increase in sum of diameters of lesions, using the smallest sum during the study as reference, including baseline (BL). Per RANO, PD= ≥25% increase in sum of products of perpendicular diameters of enhancing lesions compared to smallest tumor measurement at BL/best response, on stable/increasing corticosteroids (CS) dose; Significant/ ≥25% increase of T2/FLAIR non-enhancing lesion on stable/increasing CS dose compared to BL/best response after therapy start; Presence of new lesions/increase of enhancement; Clear progression of non-measurable disease; Definite clinical deterioration only due to tumor/decrease in CS dose; Failure to return for evaluation due to death/deterioration. Kaplan-Meier methodology was used to estimate PFS; patients without an event were censored on the last available assessment day.', 'unitOfMeasure': 'months', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'Efficacy population included all participants who received at least one dose of study treatment and either had at least one post-baseline tumor assessment or discontinued treatment for any reason. Participants who did not experience death or disease progression were censored on the day of the last available assessment.'}, {'type': 'SECONDARY', 'title': 'Duration of Response (DOR) as Determined by the Investigator According to RECIST v1.1 or RANO Criteria', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '7', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '3', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '2', 'groupId': 'OG011'}, {'value': '5', 'groupId': 'OG012'}, {'value': '1', 'groupId': 'OG013'}]}], 'groups': [{'id': 'OG000', 'title': 'Arm B: Inavolisib (GDC-0077)', 'description': 'Participants with a positive tumor biomarker result for PIK3CA activating mutation self-administered inavolisib 9 mg, orally, QD until disease progression, intolerable toxicity, or consent withdrawal whichever occurs first.'}, {'id': 'OG001', 'title': 'Arm C: Alectinib', 'description': 'Participants with a positive tumor biomarker result for ALK gene fusion self-administered alectinib, 600 mg, orally, BID until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'OG002', 'title': 'Arm D: Ipatasertib', 'description': 'Participants with a positive tumor biomarker result for phosphatase and tensin homolog (PTEN) loss/loss-of-function or protein kinase B (AKT) activating mutation self-administered ipatasertib, 400 mg orally, QD until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'OG003', 'title': 'Arm E: Atezolizumab + Chemotherapy', 'description': 'Participants with a positive tumor biomarker result for TMB-H or MSI-H or dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle in combination with investigators choice of chemotherapy (docetaxel, paclitaxel, or capecitabine) until disease progression, loss of clinical benefit, or unacceptable toxicity whichever occurs first.'}, {'id': 'OG004', 'title': 'Arm F: Trastuzumab Emtansine + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for human epidermal growth factor receptor 2 (HER2) gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by trastuzumab emtansine, 3.6 milligrams/kilograms (mg/kg), as IV infusion, every 21 days until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG005', 'title': 'Arm G: PH FDC SC', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received PH FDC SC, a loading dose of 1200 mg pertuzumab + 600 mg trastuzumab as subcutaneous (SC) injection on Day 1 of Cycle 1 followed by a maintenance dose of 600 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of each 21-day cycle, starting at Cycle 2.'}, {'id': 'OG006', 'title': 'Arm H: PH FDC SC + Chemotherapy', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received PH FDC SC, a loading dose of 1200 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of Cycle 1 followed by a maintenance dose of 600 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of each 21-day cycle, starting at Cycle 2 in combination with investigators choice of chemotherapy (docetaxel, paclitaxel, or capecitabine).'}, {'id': 'OG007', 'title': 'Arm I: Trastuzumab Emtansine + Tucatinib', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received trastuzumab emtansine, 3.6 mg/kg as IV infusion, every 21 days in combination with tucatinib, 300 mg, orally, BID starting from Cycle 1 Day 1 until disease progression or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG008', 'title': 'Arm J: Trastuzumab Emtansine + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation plus TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by trastuzumab emtansine, 3.6 mg/kg, as IV infusion, every 21 days until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG009', 'title': 'Arm K: Ipatasertib + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for PIK3CA activating mutation received ipatasertib, 400 mg, orally QD in combination with atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG010', 'title': 'Arm L: Ipatasertib + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for PTEN loss/loss-of-function or AKT-activating mutation self-administered ipatasertib, 400 mg, orally, QD and received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or intolerable toxicity, whichever occurs first.'}, {'id': 'OG011', 'title': 'Arm M: Ipatasertib + Paclitaxel', 'description': 'Participants with a positive tumor biomarker result for co-mutations in PIK3CA activating mutations and PTEN loss/loss-of-function or AKT-activating mutation self-administered ipatasertib, 400 mg, orally, QD on Days 1 to 21 of 28-day cycles and received paclitaxel, 80 mg/m\\^2, as IV infusion on Days 1, 8, and 15 of each 28-day cycle until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'OG012', 'title': 'Arm N: Atezolizumab + Tiragolumab', 'description': 'Participants with a positive tumor biomarker result for TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by tiragolumab, 600 mg, as IV infusion on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG013', 'title': 'Arm O: Pralsetinib', 'description': 'Participants with a positive tumor biomarker result for RET gene fusion self-administered pralsetinib, 400 mg, orally, QD until disease progression, intolerable toxicity, or consent withdrawal whichever occurs first.'}], 'classes': [{'categories': [{'measurements': [{'value': '5.6', 'comment': 'The upper limit of the 95% CI was not estimable because there was an insufficient number of events.', 'groupId': 'OG000', 'lowerLimit': '5.3', 'upperLimit': 'NA'}, {'value': '6.5', 'comment': 'The 95% CI was not estimable because only one participant had confirmed response, but the median was estimable because the participant had experienced an event.', 'groupId': 'OG001', 'lowerLimit': 'NA', 'upperLimit': 'NA'}, {'value': '5.5', 'comment': 'The upper limit of the 95% CI was not estimable because there was an insufficient number of events.', 'groupId': 'OG002', 'lowerLimit': '3.7', 'upperLimit': 'NA'}, {'value': 'NA', 'comment': 'The median and upper limit of the 95% CI was not estimable because there was an insufficient number of events.', 'groupId': 'OG003', 'lowerLimit': '7.4', 'upperLimit': 'NA'}, {'value': '20.0', 'comment': 'The 95% CI was not estimable because there was an insufficient number of events.', 'groupId': 'OG004', 'lowerLimit': 'NA', 'upperLimit': 'NA'}, {'value': '7.6', 'comment': 'The upper limit of the 95% CI was not estimable because there was an insufficient number of events.', 'groupId': 'OG007', 'lowerLimit': '3.7', 'upperLimit': 'NA'}, {'value': '5.5', 'comment': 'The upper limit of the 95% CI was not estimable because there was an insufficient number of events.', 'groupId': 'OG011', 'lowerLimit': '4.0', 'upperLimit': 'NA'}, {'value': 'NA', 'comment': 'The median and upper limit of the 95% CI was not estimable because there was an insufficient number of events.', 'groupId': 'OG012', 'lowerLimit': '3.6', 'upperLimit': 'NA'}, {'value': 'NA', 'comment': 'The median and 95% CI were not estimable because only one participant had confirmed response and the participant had not experienced an event (i.e., censored).', 'groupId': 'OG013', 'lowerLimit': 'NA', 'upperLimit': 'NA'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'Time from the date of the first confirmed CR/PR to PD or death from any cause (Up to 32 months)', 'description': 'DOR was defined as the time from the date of the first confirmed complete response (CR) or partial response (PR) to disease progression (PD) or death from any cause, whichever occurs first, as determined by the investigator according to RECIST v1.1 or RANO. CR \\& PR were defined per RECIST or RANO as outlined in the description for the cORR outcome measure (OM). PD was defined per RECIST or RANO as outlined in the description for the PFS OM. Kaplan-Meier methodology was used to estimate the median DOR. The 95% confidence intervals for the median DOR were computed by the method of Brookmeyer and Crowley. Participants who did not experience death or PD were censored on the day of the last available assessment.', 'unitOfMeasure': 'months', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'Efficacy population included all participants who received at least one dose of study treatment and either had at least one post-baseline tumor assessment or discontinued treatment for any reason. Participants who achieved a confirmed CR/PR were analyzed for this outcome measure.'}, {'type': 'SECONDARY', 'title': 'PFS Rate at Month 3, 6, 9, and 12 as Determined by the Investigator According to RECIST v1.1 or RANO Criteria', 'denoms': [{'units': 'Participants', 'counts': [{'value': '26', 'groupId': 'OG000'}, {'value': '5', 'groupId': 'OG001'}, {'value': '26', 'groupId': 'OG002'}, {'value': '25', 'groupId': 'OG003'}, {'value': '25', 'groupId': 'OG004'}, {'value': '13', 'groupId': 'OG005'}, {'value': '8', 'groupId': 'OG006'}, {'value': '23', 'groupId': 'OG007'}, {'value': '19', 'groupId': 'OG008'}, {'value': '28', 'groupId': 'OG009'}, {'value': '25', 'groupId': 'OG010'}, {'value': '3', 'groupId': 'OG011'}, {'value': '23', 'groupId': 'OG012'}, {'value': '3', 'groupId': 'OG013'}]}], 'groups': [{'id': 'OG000', 'title': 'Arm B: Inavolisib (GDC-0077)', 'description': 'Participants with a positive tumor biomarker result for PIK3CA activating mutation self-administered inavolisib 9 mg, orally, QD until disease progression, intolerable toxicity, or consent withdrawal whichever occurs first.'}, {'id': 'OG001', 'title': 'Arm C: Alectinib', 'description': 'Participants with a positive tumor biomarker result for ALK gene fusion self-administered alectinib, 600 mg, orally, BID until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'OG002', 'title': 'Arm D: Ipatasertib', 'description': 'Participants with a positive tumor biomarker result for phosphatase and tensin homolog (PTEN) loss/loss-of-function or protein kinase B (AKT) activating mutation self-administered ipatasertib, 400 mg orally, QD until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'OG003', 'title': 'Arm E: Atezolizumab + Chemotherapy', 'description': 'Participants with a positive tumor biomarker result for TMB-H or MSI-H or dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle in combination with investigators choice of chemotherapy (docetaxel, paclitaxel, or capecitabine) until disease progression, loss of clinical benefit, or unacceptable toxicity whichever occurs first.'}, {'id': 'OG004', 'title': 'Arm F: Trastuzumab Emtansine + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for human epidermal growth factor receptor 2 (HER2) gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by trastuzumab emtansine, 3.6 milligrams/kilograms (mg/kg), as IV infusion, every 21 days until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG005', 'title': 'Arm G: PH FDC SC', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received PH FDC SC, a loading dose of 1200 mg pertuzumab + 600 mg trastuzumab as subcutaneous (SC) injection on Day 1 of Cycle 1 followed by a maintenance dose of 600 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of each 21-day cycle, starting at Cycle 2.'}, {'id': 'OG006', 'title': 'Arm H: PH FDC SC + Chemotherapy', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received PH FDC SC, a loading dose of 1200 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of Cycle 1 followed by a maintenance dose of 600 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of each 21-day cycle, starting at Cycle 2 in combination with investigators choice of chemotherapy (docetaxel, paclitaxel, or capecitabine).'}, {'id': 'OG007', 'title': 'Arm I: Trastuzumab Emtansine + Tucatinib', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received trastuzumab emtansine, 3.6 mg/kg as IV infusion, every 21 days in combination with tucatinib, 300 mg, orally, BID starting from Cycle 1 Day 1 until disease progression or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG008', 'title': 'Arm J: Trastuzumab Emtansine + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation plus TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by trastuzumab emtansine, 3.6 mg/kg, as IV infusion, every 21 days until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG009', 'title': 'Arm K: Ipatasertib + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for PIK3CA activating mutation received ipatasertib, 400 mg, orally QD in combination with atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG010', 'title': 'Arm L: Ipatasertib + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for PTEN loss/loss-of-function or AKT-activating mutation self-administered ipatasertib, 400 mg, orally, QD and received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or intolerable toxicity, whichever occurs first.'}, {'id': 'OG011', 'title': 'Arm M: Ipatasertib + Paclitaxel', 'description': 'Participants with a positive tumor biomarker result for co-mutations in PIK3CA activating mutations and PTEN loss/loss-of-function or AKT-activating mutation self-administered ipatasertib, 400 mg, orally, QD on Days 1 to 21 of 28-day cycles and received paclitaxel, 80 mg/m\\^2, as IV infusion on Days 1, 8, and 15 of each 28-day cycle until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'OG012', 'title': 'Arm N: Atezolizumab + Tiragolumab', 'description': 'Participants with a positive tumor biomarker result for TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by tiragolumab, 600 mg, as IV infusion on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG013', 'title': 'Arm O: Pralsetinib', 'description': 'Participants with a positive tumor biomarker result for RET gene fusion self-administered pralsetinib, 400 mg, orally, QD until disease progression, intolerable toxicity, or consent withdrawal whichever occurs first.'}], 'classes': [{'title': '3 months', 'denoms': [{'units': 'Participants', 'counts': [{'value': '15', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '13', 'groupId': 'OG002'}, {'value': '12', 'groupId': 'OG003'}, {'value': '16', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}, {'value': '4', 'groupId': 'OG006'}, {'value': '10', 'groupId': 'OG007'}, {'value': '5', 'groupId': 'OG008'}, {'value': '9', 'groupId': 'OG009'}, {'value': '15', 'groupId': 'OG010'}, {'value': '2', 'groupId': 'OG011'}, {'value': '13', 'groupId': 'OG012'}, {'value': '2', 'groupId': 'OG013'}]}], 'categories': [{'measurements': [{'value': '57.69', 'groupId': 'OG000', 'lowerLimit': '38.7', 'upperLimit': '76.68'}, {'value': '50.00', 'groupId': 'OG001', 'lowerLimit': '1.00', 'upperLimit': '99.00'}, {'value': '52.00', 'groupId': 'OG002', 'lowerLimit': '32.42', 'upperLimit': '71.58'}, {'value': '52.17', 'groupId': 'OG003', 'lowerLimit': '31.76', 'upperLimit': '72.59'}, {'value': '64.00', 'groupId': 'OG004', 'lowerLimit': '45.18', 'upperLimit': '82.82'}, {'value': '41.03', 'groupId': 'OG005', 'lowerLimit': '12.19', 'upperLimit': '69.86'}, {'value': '50.00', 'groupId': 'OG006', 'lowerLimit': '15.35', 'upperLimit': '84.65'}, {'value': '48.13', 'groupId': 'OG007', 'lowerLimit': '26.77', 'upperLimit': '69.49'}, {'value': '26.32', 'groupId': 'OG008', 'lowerLimit': '6.52', 'upperLimit': '46.12'}, {'value': '35.56', 'groupId': 'OG009', 'lowerLimit': '17.13', 'upperLimit': '53.98'}, {'value': '65.22', 'groupId': 'OG010', 'lowerLimit': '45.75', 'upperLimit': '84.68'}, {'value': '66.67', 'groupId': 'OG011', 'lowerLimit': '13.32', 'upperLimit': '100.00'}, {'value': '59.09', 'groupId': 'OG012', 'lowerLimit': '38.55', 'upperLimit': '79.64'}, {'value': '66.67', 'groupId': 'OG013', 'lowerLimit': '13.32', 'upperLimit': '100.00'}]}]}, {'title': '6 months', 'denoms': [{'units': 'Participants', 'counts': [{'value': '9', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}, {'value': '7', 'groupId': 'OG003'}, {'value': '11', 'groupId': 'OG004'}, {'value': '2', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '7', 'groupId': 'OG007'}, {'value': '2', 'groupId': 'OG008'}, {'value': '3', 'groupId': 'OG009'}, {'value': '7', 'groupId': 'OG010'}, {'value': '1', 'groupId': 'OG011'}, {'value': '9', 'groupId': 'OG012'}, {'value': '1', 'groupId': 'OG013'}]}], 'categories': [{'measurements': [{'value': '37.09', 'groupId': 'OG000', 'lowerLimit': '18.15', 'upperLimit': '56.03'}, {'value': '50.00', 'groupId': 'OG001', 'lowerLimit': '1.00', 'upperLimit': '99.00'}, {'value': '36.00', 'groupId': 'OG002', 'lowerLimit': '17.18', 'upperLimit': '54.82'}, {'value': '33.20', 'groupId': 'OG003', 'lowerLimit': '13.48', 'upperLimit': '52.92'}, {'value': '44.00', 'groupId': 'OG004', 'lowerLimit': '24.54', 'upperLimit': '63.46'}, {'value': '20.51', 'groupId': 'OG005', 'lowerLimit': '0.0', 'upperLimit': '45.25'}, {'value': '12.50', 'groupId': 'OG006', 'lowerLimit': '0.00', 'upperLimit': '35.42'}, {'value': '33.69', 'groupId': 'OG007', 'lowerLimit': '13.43', 'upperLimit': '53.95'}, {'value': '10.53', 'groupId': 'OG008', 'lowerLimit': '0.00', 'upperLimit': '24.33'}, {'value': '11.85', 'groupId': 'OG009', 'lowerLimit': '0.00', 'upperLimit': '24.41'}, {'value': '33.82', 'groupId': 'OG010', 'lowerLimit': '14.13', 'upperLimit': '53.51'}, {'value': '33.33', 'groupId': 'OG011', 'lowerLimit': '0.00', 'upperLimit': '86.68'}, {'value': '40.91', 'groupId': 'OG012', 'lowerLimit': '20.36', 'upperLimit': '61.45'}, {'value': '66.67', 'groupId': 'OG013', 'lowerLimit': '13.32', 'upperLimit': '100.00'}]}]}, {'title': '9 months', 'denoms': [{'units': 'Participants', 'counts': [{'value': '5', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '6', 'groupId': 'OG003'}, {'value': '8', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '2', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '5', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}, {'value': '8', 'groupId': 'OG012'}, {'value': '0', 'groupId': 'OG013'}]}], 'categories': [{'measurements': [{'value': '20.60', 'groupId': 'OG000', 'lowerLimit': '4.61', 'upperLimit': '36.59'}, {'value': '25.00', 'groupId': 'OG001', 'lowerLimit': '0.00', 'upperLimit': '67.43'}, {'value': '9.00', 'groupId': 'OG002', 'lowerLimit': '0.00', 'upperLimit': '20.78'}, {'value': '28.46', 'groupId': 'OG003', 'lowerLimit': '9.49', 'upperLimit': '47.42'}, {'value': '32.00', 'groupId': 'OG004', 'lowerLimit': '13.71', 'upperLimit': '50.29'}, {'value': '10.26', 'groupId': 'OG005', 'lowerLimit': '0.00', 'upperLimit': '29.10'}, {'value': '19.25', 'groupId': 'OG007', 'lowerLimit': '2.32', 'upperLimit': '36.18'}, {'value': '10.53', 'groupId': 'OG008', 'lowerLimit': '0.00', 'upperLimit': '24.33'}, {'value': '3.95', 'groupId': 'OG009', 'lowerLimit': '0.00', 'upperLimit': '11.53'}, {'value': '24.15', 'groupId': 'OG010', 'lowerLimit': '6.10', 'upperLimit': '42.21'}, {'value': '36.36', 'groupId': 'OG012', 'lowerLimit': '16.26', 'upperLimit': '56.46'}]}]}, {'title': '12 months', 'denoms': [{'units': 'Participants', 'counts': [{'value': '2', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '5', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '2', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '3', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}, {'value': '7', 'groupId': 'OG012'}, {'value': '0', 'groupId': 'OG013'}]}], 'categories': [{'measurements': [{'value': '16.48', 'groupId': 'OG000', 'lowerLimit': '1.79', 'upperLimit': '31.17'}, {'value': '4.50', 'groupId': 'OG002', 'lowerLimit': '0.00', 'upperLimit': '13.08'}, {'value': '18.97', 'groupId': 'OG003', 'lowerLimit': '2.39', 'upperLimit': '35.56'}, {'value': '23.33', 'groupId': 'OG004', 'lowerLimit': '6.46', 'upperLimit': '40.21'}, {'value': '9.63', 'groupId': 'OG007', 'lowerLimit': '0.00', 'upperLimit': '22.30'}, {'value': '14.49', 'groupId': 'OG010', 'lowerLimit': '0.00', 'upperLimit': '29.49'}, {'value': '36.36', 'groupId': 'OG012', 'lowerLimit': '16.26', 'upperLimit': '56.46'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'At Months 3, 6, 9 and 12', 'description': 'The PFS rates were calculated using the Kaplan-Meier (KM) method to estimate the percent survival probability of participants (i.e., PFS event-free: did not experience PD or death from any cause) in each treatment arm at landmark timepoints. The 95% confidence intervals for each PFS rate were computed by the method of Greenwood. PFS was defined as the time from the start of study treatment to the first occurrence of PD or death from any cause, whichever occurs first, as determined by the investigator according to RECIST v1.1 or RANO. PD was defined per RECIST or RANO as outlined in the description for the PFS OM. Participants who did not experience death or PD were censored on the day of the last available assessment. The number analyzed per landmark timepoint actually represents the number of participants who remained at risk of experiencing a PFS event at that timepoint. Percentages are rounded off to the nearest decimal point.', 'unitOfMeasure': 'percent probability', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'Efficacy population included all participants who received at least one dose of study treatment and either had at least one post-baseline tumor assessment or discontinued treatment for any reason. The number analyzed per timepoint is the number of participants (out of the overall number of participants analyzed for PFS per arm) who remained at risk for a PFS event at that timepoint. Different participants may have contributed data for each timepoint.'}, {'type': 'SECONDARY', 'title': 'Percentage of Participants With Disease Control, as Determined by the Investigator According to RECIST v1.1 or RANO Criteria', 'denoms': [{'units': 'Participants', 'counts': [{'value': '26', 'groupId': 'OG000'}, {'value': '5', 'groupId': 'OG001'}, {'value': '26', 'groupId': 'OG002'}, {'value': '25', 'groupId': 'OG003'}, {'value': '25', 'groupId': 'OG004'}, {'value': '13', 'groupId': 'OG005'}, {'value': '8', 'groupId': 'OG006'}, {'value': '23', 'groupId': 'OG007'}, {'value': '19', 'groupId': 'OG008'}, {'value': '28', 'groupId': 'OG009'}, {'value': '25', 'groupId': 'OG010'}, {'value': '3', 'groupId': 'OG011'}, {'value': '23', 'groupId': 'OG012'}, {'value': '3', 'groupId': 'OG013'}]}], 'groups': [{'id': 'OG000', 'title': 'Arm B: Inavolisib (GDC-0077)', 'description': 'Participants with a positive tumor biomarker result for PIK3CA activating mutation self-administered inavolisib 9 mg, orally, QD until disease progression, intolerable toxicity, or consent withdrawal whichever occurs first.'}, {'id': 'OG001', 'title': 'Arm C: Alectinib', 'description': 'Participants with a positive tumor biomarker result for ALK gene fusion self-administered alectinib, 600 mg, orally, BID until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'OG002', 'title': 'Arm D: Ipatasertib', 'description': 'Participants with a positive tumor biomarker result for phosphatase and tensin homolog (PTEN) loss/loss-of-function or protein kinase B (AKT) activating mutation self-administered ipatasertib, 400 mg orally, QD until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'OG003', 'title': 'Arm E: Atezolizumab + Chemotherapy', 'description': 'Participants with a positive tumor biomarker result for TMB-H or MSI-H or dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle in combination with investigators choice of chemotherapy (docetaxel, paclitaxel, or capecitabine) until disease progression, loss of clinical benefit, or unacceptable toxicity whichever occurs first.'}, {'id': 'OG004', 'title': 'Arm F: Trastuzumab Emtansine + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for human epidermal growth factor receptor 2 (HER2) gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by trastuzumab emtansine, 3.6 milligrams/kilograms (mg/kg), as IV infusion, every 21 days until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG005', 'title': 'Arm G: PH FDC SC', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received PH FDC SC, a loading dose of 1200 mg pertuzumab + 600 mg trastuzumab as subcutaneous (SC) injection on Day 1 of Cycle 1 followed by a maintenance dose of 600 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of each 21-day cycle, starting at Cycle 2.'}, {'id': 'OG006', 'title': 'Arm H: PH FDC SC + Chemotherapy', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received PH FDC SC, a loading dose of 1200 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of Cycle 1 followed by a maintenance dose of 600 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of each 21-day cycle, starting at Cycle 2 in combination with investigators choice of chemotherapy (docetaxel, paclitaxel, or capecitabine).'}, {'id': 'OG007', 'title': 'Arm I: Trastuzumab Emtansine + Tucatinib', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received trastuzumab emtansine, 3.6 mg/kg as IV infusion, every 21 days in combination with tucatinib, 300 mg, orally, BID starting from Cycle 1 Day 1 until disease progression or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG008', 'title': 'Arm J: Trastuzumab Emtansine + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation plus TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by trastuzumab emtansine, 3.6 mg/kg, as IV infusion, every 21 days until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG009', 'title': 'Arm K: Ipatasertib + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for PIK3CA activating mutation received ipatasertib, 400 mg, orally QD in combination with atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG010', 'title': 'Arm L: Ipatasertib + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for PTEN loss/loss-of-function or AKT-activating mutation self-administered ipatasertib, 400 mg, orally, QD and received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or intolerable toxicity, whichever occurs first.'}, {'id': 'OG011', 'title': 'Arm M: Ipatasertib + Paclitaxel', 'description': 'Participants with a positive tumor biomarker result for co-mutations in PIK3CA activating mutations and PTEN loss/loss-of-function or AKT-activating mutation self-administered ipatasertib, 400 mg, orally, QD on Days 1 to 21 of 28-day cycles and received paclitaxel, 80 mg/m\\^2, as IV infusion on Days 1, 8, and 15 of each 28-day cycle until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'OG012', 'title': 'Arm N: Atezolizumab + Tiragolumab', 'description': 'Participants with a positive tumor biomarker result for TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by tiragolumab, 600 mg, as IV infusion on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG013', 'title': 'Arm O: Pralsetinib', 'description': 'Participants with a positive tumor biomarker result for RET gene fusion self-administered pralsetinib, 400 mg, orally, QD until disease progression, intolerable toxicity, or consent withdrawal whichever occurs first.'}], 'classes': [{'categories': [{'measurements': [{'value': '57.7', 'groupId': 'OG000', 'lowerLimit': '36.9', 'upperLimit': '76.6'}, {'value': '40.0', 'groupId': 'OG001', 'lowerLimit': '5.3', 'upperLimit': '85.3'}, {'value': '34.6', 'groupId': 'OG002', 'lowerLimit': '17.2', 'upperLimit': '55.7'}, {'value': '32.0', 'groupId': 'OG003', 'lowerLimit': '14.9', 'upperLimit': '53.5'}, {'value': '52.0', 'groupId': 'OG004', 'lowerLimit': '31.3', 'upperLimit': '72.2'}, {'value': '23.1', 'groupId': 'OG005', 'lowerLimit': '5.0', 'upperLimit': '53.8'}, {'value': '37.5', 'groupId': 'OG006', 'lowerLimit': '8.5', 'upperLimit': '75.5'}, {'value': '26.1', 'groupId': 'OG007', 'lowerLimit': '10.2', 'upperLimit': '48.4'}, {'value': '15.8', 'groupId': 'OG008', 'lowerLimit': '3.4', 'upperLimit': '39.6'}, {'value': '10.7', 'groupId': 'OG009', 'lowerLimit': '2.3', 'upperLimit': '28.2'}, {'value': '32.0', 'groupId': 'OG010', 'lowerLimit': '14.9', 'upperLimit': '53.5'}, {'value': '66.7', 'groupId': 'OG011', 'lowerLimit': '9.4', 'upperLimit': '99.2'}, {'value': '47.8', 'groupId': 'OG012', 'lowerLimit': '26.8', 'upperLimit': '69.4'}, {'value': '66.7', 'groupId': 'OG013', 'lowerLimit': '9.4', 'upperLimit': '99.2'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Up to 32 months', 'description': 'Disease control rate was defined as the percentage of participants whose best response was confirmed CR, confirmed PR, or a response of CR, PR, stable disease (SD), or non-CR/non-PD for a minimum of 98 days for 28-day cycle arms or 70 days for 21-day cycle arms after the first treatment date. CR \\& PR were defined per RECIST/RANO as outlined in the description for the cORR OM. SD per RECIST: Neither sufficient shrinkage to qualify for CR or PR nor sufficient increase to qualify for PD. SD per RANO: Participant does not qualify for CR, PR, or minor response or PD; Stable non-enhancing (T2/FLAIR) lesions or abnormalities on same or lower dose of corticosteroids compared to baseline; No new lesions or new T2 or FLAIR abnormalities apart from those consistent with radiation effect, \\& no new or increased enhancement; Participants on a should be corticosteroid dose that is not greater than dose at baseline scan \\& is stable or improved clinically; Clinical status, stable/improved.', 'unitOfMeasure': 'percentage of participants', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'Efficacy population included all participants who received at least one dose of study treatment and either had at least one post-baseline tumor assessment or discontinued treatment for any reason. Percentages have been rounded off to the nearest decimal point.'}, {'type': 'SECONDARY', 'title': 'Number of Participants With at Least One Adverse Event (AE) and Severity of AEs Determined According to National Cancer Institute Common Terminology Criteria for Adverse Events Version 5.0 (NCI CTCAE v5.0)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '26', 'groupId': 'OG000'}, {'value': '5', 'groupId': 'OG001'}, {'value': '26', 'groupId': 'OG002'}, {'value': '25', 'groupId': 'OG003'}, {'value': '25', 'groupId': 'OG004'}, {'value': '13', 'groupId': 'OG005'}, {'value': '8', 'groupId': 'OG006'}, {'value': '23', 'groupId': 'OG007'}, {'value': '19', 'groupId': 'OG008'}, {'value': '28', 'groupId': 'OG009'}, {'value': '25', 'groupId': 'OG010'}, {'value': '3', 'groupId': 'OG011'}, {'value': '23', 'groupId': 'OG012'}, {'value': '3', 'groupId': 'OG013'}]}], 'groups': [{'id': 'OG000', 'title': 'Arm B: Inavolisib (GDC-0077)', 'description': 'Participants with a positive tumor biomarker result for PIK3CA activating mutation self-administered inavolisib 9 mg, orally, QD until disease progression, intolerable toxicity, or consent withdrawal whichever occurs first.'}, {'id': 'OG001', 'title': 'Arm C: Alectinib', 'description': 'Participants with a positive tumor biomarker result for ALK gene fusion self-administered alectinib, 600 mg, orally, BID until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'OG002', 'title': 'Arm D: Ipatasertib', 'description': 'Participants with a positive tumor biomarker result for phosphatase and tensin homolog (PTEN) loss/loss-of-function or protein kinase B (AKT) activating mutation self-administered ipatasertib, 400 mg orally, QD until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'OG003', 'title': 'Arm E: Atezolizumab + Chemotherapy', 'description': 'Participants with a positive tumor biomarker result for TMB-H or MSI-H or dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle in combination with investigators choice of chemotherapy (docetaxel, paclitaxel, or capecitabine) until disease progression, loss of clinical benefit, or unacceptable toxicity whichever occurs first.'}, {'id': 'OG004', 'title': 'Arm F: Trastuzumab Emtansine + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for human epidermal growth factor receptor 2 (HER2) gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by trastuzumab emtansine, 3.6 milligrams/kilograms (mg/kg), as IV infusion, every 21 days until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG005', 'title': 'Arm G: PH FDC SC', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received PH FDC SC, a loading dose of 1200 mg pertuzumab + 600 mg trastuzumab as subcutaneous (SC) injection on Day 1 of Cycle 1 followed by a maintenance dose of 600 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of each 21-day cycle, starting at Cycle 2.'}, {'id': 'OG006', 'title': 'Arm H: PH FDC SC + Chemotherapy', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received PH FDC SC, a loading dose of 1200 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of Cycle 1 followed by a maintenance dose of 600 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of each 21-day cycle, starting at Cycle 2 in combination with investigators choice of chemotherapy (docetaxel, paclitaxel, or capecitabine).'}, {'id': 'OG007', 'title': 'Arm I: Trastuzumab Emtansine + Tucatinib', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received trastuzumab emtansine, 3.6 mg/kg as IV infusion, every 21 days in combination with tucatinib, 300 mg, orally, BID starting from Cycle 1 Day 1 until disease progression or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG008', 'title': 'Arm J: Trastuzumab Emtansine + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation plus TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by trastuzumab emtansine, 3.6 mg/kg, as IV infusion, every 21 days until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG009', 'title': 'Arm K: Ipatasertib + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for PIK3CA activating mutation received ipatasertib, 400 mg, orally QD in combination with atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG010', 'title': 'Arm L: Ipatasertib + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for PTEN loss/loss-of-function or AKT-activating mutation self-administered ipatasertib, 400 mg, orally, QD and received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or intolerable toxicity, whichever occurs first.'}, {'id': 'OG011', 'title': 'Arm M: Ipatasertib + Paclitaxel', 'description': 'Participants with a positive tumor biomarker result for co-mutations in PIK3CA activating mutations and PTEN loss/loss-of-function or AKT-activating mutation self-administered ipatasertib, 400 mg, orally, QD on Days 1 to 21 of 28-day cycles and received paclitaxel, 80 mg/m\\^2, as IV infusion on Days 1, 8, and 15 of each 28-day cycle until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'OG012', 'title': 'Arm N: Atezolizumab + Tiragolumab', 'description': 'Participants with a positive tumor biomarker result for TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by tiragolumab, 600 mg, as IV infusion on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'OG013', 'title': 'Arm O: Pralsetinib', 'description': 'Participants with a positive tumor biomarker result for RET gene fusion self-administered pralsetinib, 400 mg, orally, QD until disease progression, intolerable toxicity, or consent withdrawal whichever occurs first.'}], 'classes': [{'title': 'Any Adverse Event (AE), Any Grade', 'categories': [{'measurements': [{'value': '25', 'groupId': 'OG000'}, {'value': '5', 'groupId': 'OG001'}, {'value': '25', 'groupId': 'OG002'}, {'value': '25', 'groupId': 'OG003'}, {'value': '24', 'groupId': 'OG004'}, {'value': '11', 'groupId': 'OG005'}, {'value': '8', 'groupId': 'OG006'}, {'value': '23', 'groupId': 'OG007'}, {'value': '19', 'groupId': 'OG008'}, {'value': '27', 'groupId': 'OG009'}, {'value': '25', 'groupId': 'OG010'}, {'value': '3', 'groupId': 'OG011'}, {'value': '21', 'groupId': 'OG012'}, {'value': '3', 'groupId': 'OG013'}]}]}, {'title': 'Highest Severity: Grade 1 AEs', 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '1', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}, {'value': '1', 'groupId': 'OG012'}, {'value': '0', 'groupId': 'OG013'}]}]}, {'title': 'Highest Severity: Grade 2 AEs', 'categories': [{'measurements': [{'value': '14', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}, {'value': '9', 'groupId': 'OG003'}, {'value': '10', 'groupId': 'OG004'}, {'value': '6', 'groupId': 'OG005'}, {'value': '3', 'groupId': 'OG006'}, {'value': '11', 'groupId': 'OG007'}, {'value': '7', 'groupId': 'OG008'}, {'value': '7', 'groupId': 'OG009'}, {'value': '11', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}, {'value': '11', 'groupId': 'OG012'}, {'value': '0', 'groupId': 'OG013'}]}]}, {'title': 'Highest Severity: Grade 3 AEs', 'categories': [{'measurements': [{'value': '6', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '9', 'groupId': 'OG002'}, {'value': '11', 'groupId': 'OG003'}, {'value': '11', 'groupId': 'OG004'}, {'value': '2', 'groupId': 'OG005'}, {'value': '4', 'groupId': 'OG006'}, {'value': '7', 'groupId': 'OG007'}, {'value': '11', 'groupId': 'OG008'}, {'value': '16', 'groupId': 'OG009'}, {'value': '10', 'groupId': 'OG010'}, {'value': '3', 'groupId': 'OG011'}, {'value': '8', 'groupId': 'OG012'}, {'value': '2', 'groupId': 'OG013'}]}]}, {'title': 'Highest Severity: Grade 4 AEs', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '1', 'groupId': 'OG009'}, {'value': '2', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}, {'value': '0', 'groupId': 'OG012'}, {'value': '0', 'groupId': 'OG013'}]}]}, {'title': 'Highest Severity: Grade 5 AEs', 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '1', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '2', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '0', 'groupId': 'OG011'}, {'value': '1', 'groupId': 'OG012'}, {'value': '1', 'groupId': 'OG013'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'From initiation of study drug until 28 days after the final dose of study drugs other than atezolizumab and until 90 days after the final dose of atezolizumab (Up to 32 months)', 'description': 'An AE is an untoward medical occurrence in participant administered a pharmaceutical product \\& regardless of causal relationship with the product. An AE can therefore be any unfavorable \\& unintended sign (including an abnormal laboratory finding), symptom/disease temporally associated with use of investigational product, whether or not considered related to it. AEs were graded for severity according to NCI CTCAE v5.0. Grade 1= Mild; asymptomatic or mild symptoms; clinical or diagnostic observations only; or intervention not indicated; Grade 2=Moderate; minimal, local or non-invasive intervention indicated; or limiting age-appropriate instrumental activities of daily living; Grade 3 = Severe or medically significant, but not immediately life-threatening; hospitalization or prolongation of hospitalization indicated; disabling; or limiting self-care activities of daily living; Grade 4= Life-threatening consequences/urgent intervention indicated; Grade 5= Death related to adverse event.', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'Safety evaluable population included all participants who received at least one dose of the study drug.'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'Arm B: Inavolisib (GDC-0077)', 'description': 'Participants with a positive tumor biomarker result for phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) activating mutation self-administered inavolisib 9 milligrams (mg), orally, once a day (QD) until disease progression, intolerable toxicity, or consent withdrawal whichever occurs first.'}, {'id': 'FG001', 'title': 'Arm C: Alectinib', 'description': 'Participants with a positive tumor biomarker result for anaplastic lymphoma kinase (ALK) gene fusion self-administered alectinib, 600 mg, orally, twice a day (BID) until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'FG002', 'title': 'Arm D: Ipatasertib', 'description': 'Participants with a positive tumor biomarker result for phosphatase and tensin homolog (PTEN) loss/loss-of-function or protein kinase B (AKT) activating mutation self-administered ipatasertib, 400 mg orally, QD until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'FG003', 'title': 'Arm E: Atezolizumab + Chemotherapy', 'description': 'Participants with a positive tumor biomarker result for tumor mutational burden-high (TMB-H) or microsatellite instability high (MSI-H) or deficient mismatch repair (dMMR) received atezolizumab,1200 mg, as intravenous (IV) infusion, on Day 1 of each 21-day cycle in combination with investigators choice of chemotherapy (docetaxel, paclitaxel, or capecitabine) until disease progression, loss of clinical benefit, or unacceptable toxicity whichever occurs first.'}, {'id': 'FG004', 'title': 'Arm F: Trastuzumab Emtansine + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for human epidermal growth factor receptor 2 (HER2) gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by trastuzumab emtansine, 3.6 milligrams/kilograms (mg/kg), as IV infusion, every 21 days until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'FG005', 'title': 'Arm G: PH FDC SC', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received PH FDC SC, a loading dose of 1200 mg pertuzumab + 600 mg trastuzumab as subcutaneous (SC) injection on Day 1 of Cycle 1 followed by a maintenance dose of 600 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of each 21-day cycle, starting at Cycle 2.'}, {'id': 'FG006', 'title': 'Arm H: PH FDC SC + Chemotherapy', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received PH FDC SC, a loading dose of 1200 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of Cycle 1 followed by a maintenance dose of 600 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of each 21-day cycle, starting at Cycle 2 in combination with investigators choice of chemotherapy (docetaxel, paclitaxel, or capecitabine).'}, {'id': 'FG007', 'title': 'Arm I: Trastuzumab Emtansine + Tucatinib', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received trastuzumab emtansine, 3.6 mg/kg as IV infusion, every 21 days in combination with tucatinib, 300 mg, orally, BID starting from Cycle 1 Day 1 until disease progression or unacceptable toxicity, whichever occurs first.'}, {'id': 'FG008', 'title': 'Arm J: Trastuzumab Emtansine + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation plus TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by trastuzumab emtansine, 3.6 mg/kg, as IV infusion, every 21 days until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'FG009', 'title': 'Arm K: Ipatasertib + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for PIK3CA activating mutation received ipatasertib, 400 mg, orally QD in combination with atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'FG010', 'title': 'Arm L: Ipatasertib + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for PTEN loss/loss-of-function or AKT-activating mutation self-administered ipatasertib, 400 mg, orally, QD and received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or intolerable toxicity, whichever occurs first.'}, {'id': 'FG011', 'title': 'Arm M: Ipatasertib + Paclitaxel', 'description': 'Participants with a positive tumor biomarker result for co-mutations in PIK3CA activating mutations and PTEN loss/loss-of-function or AKT-activating mutation self-administered ipatasertib, 400 mg, orally, QD on Days 1 to 21 of 28-day cycles and received paclitaxel, 80 milligrams per meter square (mg/m\\^2), as IV infusion on Days 1, 8, and 15 of each 28-day cycle until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'FG012', 'title': 'Arm N: Atezolizumab + Tiragolumab', 'description': 'Participants with a positive tumor biomarker result for TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by tiragolumab, 600 mg, as IV infusion on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'FG013', 'title': 'Arm O: Pralsetinib', 'description': 'Participants with a positive tumor biomarker result for rearranged during transfection (RET) gene fusion self-administered pralsetinib, 400 mg, orally, QD until disease progression, intolerable toxicity, or consent withdrawal whichever occurs first.'}], 'periods': [{'title': 'Overall Study', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '26'}, {'groupId': 'FG001', 'numSubjects': '5'}, {'groupId': 'FG002', 'numSubjects': '26'}, {'groupId': 'FG003', 'numSubjects': '25'}, {'groupId': 'FG004', 'numSubjects': '25'}, {'groupId': 'FG005', 'numSubjects': '13'}, {'groupId': 'FG006', 'numSubjects': '8'}, {'groupId': 'FG007', 'numSubjects': '23'}, {'groupId': 'FG008', 'numSubjects': '19'}, {'groupId': 'FG009', 'numSubjects': '28'}, {'groupId': 'FG010', 'numSubjects': '25'}, {'groupId': 'FG011', 'numSubjects': '3'}, {'groupId': 'FG012', 'numSubjects': '23'}, {'groupId': 'FG013', 'numSubjects': '3'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '2'}, {'groupId': 'FG001', 'numSubjects': '3'}, {'groupId': 'FG002', 'numSubjects': '5'}, {'groupId': 'FG003', 'numSubjects': '4'}, {'groupId': 'FG004', 'numSubjects': '5'}, {'groupId': 'FG005', 'numSubjects': '4'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '5'}, {'groupId': 'FG008', 'numSubjects': '3'}, {'groupId': 'FG009', 'numSubjects': '4'}, {'groupId': 'FG010', 'numSubjects': '5'}, {'groupId': 'FG011', 'numSubjects': '1'}, {'groupId': 'FG012', 'numSubjects': '6'}, {'groupId': 'FG013', 'numSubjects': '1'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '24'}, {'groupId': 'FG001', 'numSubjects': '2'}, {'groupId': 'FG002', 'numSubjects': '21'}, {'groupId': 'FG003', 'numSubjects': '21'}, {'groupId': 'FG004', 'numSubjects': '20'}, {'groupId': 'FG005', 'numSubjects': '9'}, {'groupId': 'FG006', 'numSubjects': '8'}, {'groupId': 'FG007', 'numSubjects': '18'}, {'groupId': 'FG008', 'numSubjects': '16'}, {'groupId': 'FG009', 'numSubjects': '24'}, {'groupId': 'FG010', 'numSubjects': '20'}, {'groupId': 'FG011', 'numSubjects': '2'}, {'groupId': 'FG012', 'numSubjects': '17'}, {'groupId': 'FG013', 'numSubjects': '2'}]}], 'dropWithdraws': [{'type': 'Adverse Event', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '0'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '0'}, {'groupId': 'FG008', 'numSubjects': '0'}, {'groupId': 'FG009', 'numSubjects': '0'}, {'groupId': 'FG010', 'numSubjects': '0'}, {'groupId': 'FG011', 'numSubjects': '0'}, {'groupId': 'FG012', 'numSubjects': '1'}, {'groupId': 'FG013', 'numSubjects': '0'}]}, {'type': 'Death', 'reasons': [{'groupId': 'FG000', 'numSubjects': '17'}, {'groupId': 'FG001', 'numSubjects': '1'}, {'groupId': 'FG002', 'numSubjects': '14'}, {'groupId': 'FG003', 'numSubjects': '14'}, {'groupId': 'FG004', 'numSubjects': '13'}, {'groupId': 'FG005', 'numSubjects': '6'}, {'groupId': 'FG006', 'numSubjects': '7'}, {'groupId': 'FG007', 'numSubjects': '12'}, {'groupId': 'FG008', 'numSubjects': '15'}, {'groupId': 'FG009', 'numSubjects': '20'}, {'groupId': 'FG010', 'numSubjects': '8'}, {'groupId': 'FG011', 'numSubjects': '2'}, {'groupId': 'FG012', 'numSubjects': '10'}, {'groupId': 'FG013', 'numSubjects': '1'}]}, {'type': 'Lost to Follow-up', 'reasons': [{'groupId': 'FG000', 'numSubjects': '1'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '1'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '2'}, {'groupId': 'FG005', 'numSubjects': '0'}, {'groupId': 'FG006', 'numSubjects': '1'}, {'groupId': 'FG007', 'numSubjects': '1'}, {'groupId': 'FG008', 'numSubjects': '1'}, {'groupId': 'FG009', 'numSubjects': '1'}, {'groupId': 'FG010', 'numSubjects': '2'}, {'groupId': 'FG011', 'numSubjects': '0'}, {'groupId': 'FG012', 'numSubjects': '0'}, {'groupId': 'FG013', 'numSubjects': '0'}]}, {'type': 'Reason not Specified', 'reasons': [{'groupId': 'FG000', 'numSubjects': '2'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '1'}, {'groupId': 'FG003', 'numSubjects': '1'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '0'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '0'}, {'groupId': 'FG008', 'numSubjects': '0'}, {'groupId': 'FG009', 'numSubjects': '0'}, {'groupId': 'FG010', 'numSubjects': '1'}, {'groupId': 'FG011', 'numSubjects': '0'}, {'groupId': 'FG012', 'numSubjects': '0'}, {'groupId': 'FG013', 'numSubjects': '0'}]}, {'type': 'Physician Decision', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '2'}, {'groupId': 'FG004', 'numSubjects': '1'}, {'groupId': 'FG005', 'numSubjects': '0'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '0'}, {'groupId': 'FG008', 'numSubjects': '0'}, {'groupId': 'FG009', 'numSubjects': '0'}, {'groupId': 'FG010', 'numSubjects': '0'}, {'groupId': 'FG011', 'numSubjects': '0'}, {'groupId': 'FG012', 'numSubjects': '3'}, {'groupId': 'FG013', 'numSubjects': '0'}]}, {'type': 'Progressive Disease', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '1'}, {'groupId': 'FG005', 'numSubjects': '0'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '0'}, {'groupId': 'FG008', 'numSubjects': '0'}, {'groupId': 'FG009', 'numSubjects': '1'}, {'groupId': 'FG010', 'numSubjects': '1'}, {'groupId': 'FG011', 'numSubjects': '0'}, {'groupId': 'FG012', 'numSubjects': '2'}, {'groupId': 'FG013', 'numSubjects': '0'}]}, {'type': 'Withdrawal by Subject', 'reasons': [{'groupId': 'FG000', 'numSubjects': '4'}, {'groupId': 'FG001', 'numSubjects': '1'}, {'groupId': 'FG002', 'numSubjects': '5'}, {'groupId': 'FG003', 'numSubjects': '4'}, {'groupId': 'FG004', 'numSubjects': '3'}, {'groupId': 'FG005', 'numSubjects': '3'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '5'}, {'groupId': 'FG008', 'numSubjects': '0'}, {'groupId': 'FG009', 'numSubjects': '2'}, {'groupId': 'FG010', 'numSubjects': '8'}, {'groupId': 'FG011', 'numSubjects': '0'}, {'groupId': 'FG012', 'numSubjects': '1'}, {'groupId': 'FG013', 'numSubjects': '1'}]}]}], 'recruitmentDetails': 'A total of 252 participants with advanced unresectable or metastatic solid tumors with positive biomarker result took part in the study across 38 investigative sites in the United States.', 'preAssignmentDetails': 'Participants in this multi-arm study were treated with a drug or drug regimen tailored to their biomarker identified at screening. A total of 15 arms (Arms A to O) were planned for this study. However, no participants were enrolled in Arm A.'}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '26', 'groupId': 'BG000'}, {'value': '5', 'groupId': 'BG001'}, {'value': '26', 'groupId': 'BG002'}, {'value': '25', 'groupId': 'BG003'}, {'value': '25', 'groupId': 'BG004'}, {'value': '13', 'groupId': 'BG005'}, {'value': '8', 'groupId': 'BG006'}, {'value': '23', 'groupId': 'BG007'}, {'value': '19', 'groupId': 'BG008'}, {'value': '28', 'groupId': 'BG009'}, {'value': '25', 'groupId': 'BG010'}, {'value': '3', 'groupId': 'BG011'}, {'value': '23', 'groupId': 'BG012'}, {'value': '3', 'groupId': 'BG013'}, {'value': '252', 'groupId': 'BG014'}]}], 'groups': [{'id': 'BG000', 'title': 'Arm B: Inavolisib (GDC-0077)', 'description': 'Participants with a positive tumor biomarker result for PIK3CA activating mutation self-administered inavolisib 9 mg, orally, QD until disease progression, intolerable toxicity, or consent withdrawal whichever occurs first.'}, {'id': 'BG001', 'title': 'Arm C: Alectinib', 'description': 'Participants with a positive tumor biomarker result for ALK gene fusion self-administered alectinib, 600 mg, orally, BID until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'BG002', 'title': 'Arm D: Ipatasertib', 'description': 'Participants with a positive tumor biomarker result for phosphatase and tensin homolog (PTEN) loss/loss-of-function or protein kinase B (AKT) activating mutation self-administered ipatasertib, 400 mg orally, QD until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'BG003', 'title': 'Arm E: Atezolizumab + Chemotherapy', 'description': 'Participants with a positive tumor biomarker result for TMB-H or MSI-H or dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle in combination with investigators choice of chemotherapy (docetaxel, paclitaxel, or capecitabine) until disease progression, loss of clinical benefit, or unacceptable toxicity whichever occurs first.'}, {'id': 'BG004', 'title': 'Arm F: Trastuzumab Emtansine + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for human epidermal growth factor receptor 2 (HER2) gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by trastuzumab emtansine, 3.6 milligrams/kilograms (mg/kg), as IV infusion, every 21 days until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'BG005', 'title': 'Arm G: PH FDC SC', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received PH FDC SC, a loading dose of 1200 mg pertuzumab + 600 mg trastuzumab as subcutaneous (SC) injection on Day 1 of Cycle 1 followed by a maintenance dose of 600 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of each 21-day cycle, starting at Cycle 2.'}, {'id': 'BG006', 'title': 'Arm H: PH FDC SC + Chemotherapy', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received PH FDC SC, a loading dose of 1200 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of Cycle 1 followed by a maintenance dose of 600 mg pertuzumab + 600 mg trastuzumab as a SC injection on Day 1 of each 21-day cycle, starting at Cycle 2 in combination with investigators choice of chemotherapy (docetaxel, paclitaxel, or capecitabine).'}, {'id': 'BG007', 'title': 'Arm I: Trastuzumab Emtansine + Tucatinib', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation without known TMB-H/ MSI-H/ dMMR received trastuzumab emtansine, 3.6 mg/kg as IV infusion, every 21 days in combination with tucatinib, 300 mg, orally, BID starting from Cycle 1 Day 1 until disease progression or unacceptable toxicity, whichever occurs first.'}, {'id': 'BG008', 'title': 'Arm J: Trastuzumab Emtansine + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for HER2 gene amplification or mutation plus TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by trastuzumab emtansine, 3.6 mg/kg, as IV infusion, every 21 days until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'BG009', 'title': 'Arm K: Ipatasertib + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for PIK3CA activating mutation received ipatasertib, 400 mg, orally QD in combination with atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'BG010', 'title': 'Arm L: Ipatasertib + Atezolizumab', 'description': 'Participants with a positive tumor biomarker result for PTEN loss/loss-of-function or AKT-activating mutation self-administered ipatasertib, 400 mg, orally, QD and received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or intolerable toxicity, whichever occurs first.'}, {'id': 'BG011', 'title': 'Arm M: Ipatasertib + Paclitaxel', 'description': 'Participants with a positive tumor biomarker result for co-mutations in PIK3CA activating mutations and PTEN loss/loss-of-function or AKT-activating mutation self-administered ipatasertib, 400 mg, orally, QD on Days 1 to 21 of 28-day cycles and received paclitaxel, 80 mg/m\\^2, as IV infusion on Days 1, 8, and 15 of each 28-day cycle until disease progression, intolerable toxicity, or consent withdrawal, whichever occurs first.'}, {'id': 'BG012', 'title': 'Arm N: Atezolizumab + Tiragolumab', 'description': 'Participants with a positive tumor biomarker result for TMB-H/ MSI-H/ dMMR received atezolizumab, 1200 mg, as IV infusion, on Day 1 of each 21-day cycle, followed by tiragolumab, 600 mg, as IV infusion on Day 1 of each 21-day cycle until disease progression, loss of clinical benefit, or unacceptable toxicity, whichever occurs first.'}, {'id': 'BG013', 'title': 'Arm O: Pralsetinib', 'description': 'Participants with a positive tumor biomarker result for RET gene fusion self-administered pralsetinib, 400 mg, orally, QD until disease progression, intolerable toxicity, or consent withdrawal whichever occurs first.'}, {'id': 'BG014', 'title': 'Total', 'description': 'Total of all reporting groups'}], 'measures': [{'title': 'Age, Continuous', 'classes': [{'categories': [{'measurements': [{'value': '64.5', 'spread': '11.5', 'groupId': 'BG000'}, {'value': '62.6', 'spread': '6.7', 'groupId': 'BG001'}, {'value': '66.7', 'spread': '10.0', 'groupId': 'BG002'}, {'value': '66.0', 'spread': '12.0', 'groupId': 'BG003'}, {'value': '66.1', 'spread': '12.9', 'groupId': 'BG004'}, {'value': '63.8', 'spread': '10.7', 'groupId': 'BG005'}, {'value': '61.1', 'spread': '12.8', 'groupId': 'BG006'}, {'value': '64.2', 'spread': '12.0', 'groupId': 'BG007'}, {'value': '61.8', 'spread': '10.7', 'groupId': 'BG008'}, {'value': '60.3', 'spread': '10.4', 'groupId': 'BG009'}, {'value': '59.8', 'spread': '11.4', 'groupId': 'BG010'}, {'value': '57.7', 'spread': '19.4', 'groupId': 'BG011'}, {'value': '63.7', 'spread': '11.0', 'groupId': 'BG012'}, {'value': '71.3', 'spread': '16.2', 'groupId': 'BG013'}, {'value': '63.6', 'spread': '11.4', 'groupId': 'BG014'}]}]}], 'paramType': 'MEAN', 'unitOfMeasure': 'years', 'dispersionType': 'STANDARD_DEVIATION'}, {'title': 'Sex: Female, Male', 'classes': [{'categories': [{'title': 'Female', 'measurements': [{'value': '18', 'groupId': 'BG000'}, {'value': '4', 'groupId': 'BG001'}, {'value': '18', 'groupId': 'BG002'}, {'value': '11', 'groupId': 'BG003'}, {'value': '8', 'groupId': 'BG004'}, {'value': '7', 'groupId': 'BG005'}, {'value': '5', 'groupId': 'BG006'}, {'value': '15', 'groupId': 'BG007'}, {'value': '9', 'groupId': 'BG008'}, {'value': '19', 'groupId': 'BG009'}, {'value': '15', 'groupId': 'BG010'}, {'value': '2', 'groupId': 'BG011'}, {'value': '14', 'groupId': 'BG012'}, {'value': '1', 'groupId': 'BG013'}, {'value': '146', 'groupId': 'BG014'}]}, {'title': 'Male', 'measurements': [{'value': '8', 'groupId': 'BG000'}, {'value': '1', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '14', 'groupId': 'BG003'}, {'value': '17', 'groupId': 'BG004'}, {'value': '6', 'groupId': 'BG005'}, {'value': '3', 'groupId': 'BG006'}, {'value': '8', 'groupId': 'BG007'}, {'value': '10', 'groupId': 'BG008'}, {'value': '9', 'groupId': 'BG009'}, {'value': '10', 'groupId': 'BG010'}, {'value': '1', 'groupId': 'BG011'}, {'value': '9', 'groupId': 'BG012'}, {'value': '2', 'groupId': 'BG013'}, {'value': '106', 'groupId': 'BG014'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Ethnicity (NIH/OMB)', 'classes': [{'categories': [{'title': 'Hispanic or Latino', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '2', 'groupId': 'BG002'}, {'value': '1', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '1', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '2', 'groupId': 'BG007'}, {'value': '1', 'groupId': 'BG008'}, {'value': '1', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '3', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '11', 'groupId': 'BG014'}]}, {'title': 'Not Hispanic or Latino', 'measurements': [{'value': '26', 'groupId': 'BG000'}, {'value': '5', 'groupId': 'BG001'}, {'value': '24', 'groupId': 'BG002'}, {'value': '24', 'groupId': 'BG003'}, {'value': '24', 'groupId': 'BG004'}, {'value': '12', 'groupId': 'BG005'}, {'value': '6', 'groupId': 'BG006'}, {'value': '20', 'groupId': 'BG007'}, {'value': '17', 'groupId': 'BG008'}, {'value': '26', 'groupId': 'BG009'}, {'value': '25', 'groupId': 'BG010'}, {'value': '3', 'groupId': 'BG011'}, {'value': '20', 'groupId': 'BG012'}, {'value': '3', 'groupId': 'BG013'}, {'value': '235', 'groupId': 'BG014'}]}, {'title': 'Unknown or Not Reported', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '1', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '2', 'groupId': 'BG006'}, {'value': '1', 'groupId': 'BG007'}, {'value': '1', 'groupId': 'BG008'}, {'value': '1', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '0', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '6', 'groupId': 'BG014'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Race (NIH/OMB)', 'classes': [{'categories': [{'title': 'American Indian or Alaska Native', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '0', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '0', 'groupId': 'BG014'}]}, {'title': 'Asian', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '1', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '2', 'groupId': 'BG007'}, {'value': '1', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '2', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '0', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '6', 'groupId': 'BG014'}]}, {'title': 'Native Hawaiian or Other Pacific Islander', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '0', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '0', 'groupId': 'BG014'}]}, {'title': 'Black or African American', 'measurements': [{'value': '2', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '4', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '4', 'groupId': 'BG004'}, {'value': '1', 'groupId': 'BG005'}, {'value': '2', 'groupId': 'BG006'}, {'value': '1', 'groupId': 'BG007'}, {'value': '3', 'groupId': 'BG008'}, {'value': '2', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '4', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '23', 'groupId': 'BG014'}]}, {'title': 'White', 'measurements': [{'value': '24', 'groupId': 'BG000'}, {'value': '5', 'groupId': 'BG001'}, {'value': '21', 'groupId': 'BG002'}, {'value': '24', 'groupId': 'BG003'}, {'value': '20', 'groupId': 'BG004'}, {'value': '12', 'groupId': 'BG005'}, {'value': '4', 'groupId': 'BG006'}, {'value': '20', 'groupId': 'BG007'}, {'value': '12', 'groupId': 'BG008'}, {'value': '24', 'groupId': 'BG009'}, {'value': '23', 'groupId': 'BG010'}, {'value': '3', 'groupId': 'BG011'}, {'value': '19', 'groupId': 'BG012'}, {'value': '3', 'groupId': 'BG013'}, {'value': '214', 'groupId': 'BG014'}]}, {'title': 'More than one race', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '0', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '0', 'groupId': 'BG014'}]}, {'title': 'Unknown or Not Reported', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '1', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '2', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '3', 'groupId': 'BG008'}, {'value': '2', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '0', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '9', 'groupId': 'BG014'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}], 'populationDescription': 'Safety evaluable population included all participants who received at least one dose of the study drug.'}}, 'documentSection': {'largeDocumentModule': {'largeDocs': [{'date': '2023-02-28', 'size': 7087339, 'label': 'Study Protocol', 'hasIcf': False, 'hasSap': False, 'filename': 'Prot_000.pdf', 'typeAbbrev': 'Prot', 'uploadDate': '2024-11-11T13:23', 'hasProtocol': True}, {'date': '2021-10-21', 'size': 894441, 'label': 'Statistical Analysis Plan', 'hasIcf': False, 'hasSap': True, 'filename': 'SAP_001.pdf', 'typeAbbrev': 'SAP', 'uploadDate': '2024-11-11T13:23', 'hasProtocol': False}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE2'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NON_RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 252}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2021-01-13', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2024-12', 'completionDateStruct': {'date': '2024-02-27', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2024-12-16', 'studyFirstSubmitDate': '2020-11-12', 'resultsFirstSubmitDate': '2024-11-11', 'studyFirstSubmitQcDate': '2020-11-12', 'lastUpdatePostDateStruct': {'date': '2025-01-08', 'type': 'ACTUAL'}, 'resultsFirstSubmitQcDate': '2024-12-16', 'studyFirstPostDateStruct': {'date': '2020-11-17', 'type': 'ACTUAL'}, 'resultsFirstPostDateStruct': {'date': '2025-01-08', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2023-12-04', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Confirmed Objective Response Rate (ORR) Assessed by Investigator According to Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1) or Response Assessment in Neuro-Oncology (RANO) Criteria for Primary Central Nervous System (CNS) Tumors', 'timeFrame': 'Up to 32 months', 'description': 'Confirmed objective response rate (cORR)=percentage of participants with best response as complete response (CR) or partial response (PR) for measurable disease \\& CR for non-measurable disease. Confirmation=CR/PR on 2 consecutive visits ≥4 weeks apart for 3-week cycles \\& ≥6 weeks apart for 4-week cycles. Per RECIST, CR=disappearance of all target lesions. PR= ≥30% decrease in sum of diameters of target lesions, in absence of CR. Per RANO, CR=complete disappearance of all measurable \\& non-measurable disease for ≥4 weeks; no new lesions/abnormality on T2/FLAIR imaging; stable/improved non-enhancing lesions; participants must be off corticosteroids or on physiological doses; clinical status stable/improved. PR= ≥50% decrease in the sum of products of perpendicular diameters of measurable enhancing lesions on T2/FLAIR imaging for ≥4 weeks; no progression of non-measurable T1 disease; stable/improved non-enhancing lesions; corticosteroid dose ≤ baseline; clinical status stable/improved.'}], 'secondaryOutcomes': [{'measure': 'Progression-Free Survival (PFS) as Determined by the Investigator According to RECIST v1.1 or RANO Criteria', 'timeFrame': 'Time from start of treatment to the first occurrence of disease progression or death from any cause (Up to 32 months)', 'description': 'PFS=time from start of treatment to the first occurrence of disease progression (PD) or death from any cause, whichever occurs first, per RECIST v1.1, or RANO. Per RECIST, PD=≥20% increase in sum of diameters of lesions, using the smallest sum during the study as reference, including baseline (BL). Per RANO, PD= ≥25% increase in sum of products of perpendicular diameters of enhancing lesions compared to smallest tumor measurement at BL/best response, on stable/increasing corticosteroids (CS) dose; Significant/ ≥25% increase of T2/FLAIR non-enhancing lesion on stable/increasing CS dose compared to BL/best response after therapy start; Presence of new lesions/increase of enhancement; Clear progression of non-measurable disease; Definite clinical deterioration only due to tumor/decrease in CS dose; Failure to return for evaluation due to death/deterioration. Kaplan-Meier methodology was used to estimate PFS; patients without an event were censored on the last available assessment day.'}, {'measure': 'Duration of Response (DOR) as Determined by the Investigator According to RECIST v1.1 or RANO Criteria', 'timeFrame': 'Time from the date of the first confirmed CR/PR to PD or death from any cause (Up to 32 months)', 'description': 'DOR was defined as the time from the date of the first confirmed complete response (CR) or partial response (PR) to disease progression (PD) or death from any cause, whichever occurs first, as determined by the investigator according to RECIST v1.1 or RANO. CR \\& PR were defined per RECIST or RANO as outlined in the description for the cORR outcome measure (OM). PD was defined per RECIST or RANO as outlined in the description for the PFS OM. Kaplan-Meier methodology was used to estimate the median DOR. The 95% confidence intervals for the median DOR were computed by the method of Brookmeyer and Crowley. Participants who did not experience death or PD were censored on the day of the last available assessment.'}, {'measure': 'PFS Rate at Month 3, 6, 9, and 12 as Determined by the Investigator According to RECIST v1.1 or RANO Criteria', 'timeFrame': 'At Months 3, 6, 9 and 12', 'description': 'The PFS rates were calculated using the Kaplan-Meier (KM) method to estimate the percent survival probability of participants (i.e., PFS event-free: did not experience PD or death from any cause) in each treatment arm at landmark timepoints. The 95% confidence intervals for each PFS rate were computed by the method of Greenwood. PFS was defined as the time from the start of study treatment to the first occurrence of PD or death from any cause, whichever occurs first, as determined by the investigator according to RECIST v1.1 or RANO. PD was defined per RECIST or RANO as outlined in the description for the PFS OM. Participants who did not experience death or PD were censored on the day of the last available assessment. The number analyzed per landmark timepoint actually represents the number of participants who remained at risk of experiencing a PFS event at that timepoint. Percentages are rounded off to the nearest decimal point.'}, {'measure': 'Percentage of Participants With Disease Control, as Determined by the Investigator According to RECIST v1.1 or RANO Criteria', 'timeFrame': 'Up to 32 months', 'description': 'Disease control rate was defined as the percentage of participants whose best response was confirmed CR, confirmed PR, or a response of CR, PR, stable disease (SD), or non-CR/non-PD for a minimum of 98 days for 28-day cycle arms or 70 days for 21-day cycle arms after the first treatment date. CR \\& PR were defined per RECIST/RANO as outlined in the description for the cORR OM. SD per RECIST: Neither sufficient shrinkage to qualify for CR or PR nor sufficient increase to qualify for PD. SD per RANO: Participant does not qualify for CR, PR, or minor response or PD; Stable non-enhancing (T2/FLAIR) lesions or abnormalities on same or lower dose of corticosteroids compared to baseline; No new lesions or new T2 or FLAIR abnormalities apart from those consistent with radiation effect, \\& no new or increased enhancement; Participants on a should be corticosteroid dose that is not greater than dose at baseline scan \\& is stable or improved clinically; Clinical status, stable/improved.'}, {'measure': 'Number of Participants With at Least One Adverse Event (AE) and Severity of AEs Determined According to National Cancer Institute Common Terminology Criteria for Adverse Events Version 5.0 (NCI CTCAE v5.0)', 'timeFrame': 'From initiation of study drug until 28 days after the final dose of study drugs other than atezolizumab and until 90 days after the final dose of atezolizumab (Up to 32 months)', 'description': 'An AE is an untoward medical occurrence in participant administered a pharmaceutical product \\& regardless of causal relationship with the product. An AE can therefore be any unfavorable \\& unintended sign (including an abnormal laboratory finding), symptom/disease temporally associated with use of investigational product, whether or not considered related to it. AEs were graded for severity according to NCI CTCAE v5.0. Grade 1= Mild; asymptomatic or mild symptoms; clinical or diagnostic observations only; or intervention not indicated; Grade 2=Moderate; minimal, local or non-invasive intervention indicated; or limiting age-appropriate instrumental activities of daily living; Grade 3 = Severe or medically significant, but not immediately life-threatening; hospitalization or prolongation of hospitalization indicated; disabling; or limiting self-care activities of daily living; Grade 4= Life-threatening consequences/urgent intervention indicated; Grade 5= Death related to adverse event.'}]}, 'oversightModule': {'isFdaRegulatedDrug': True, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Advanced Unresectable or Metastatic Solid Malignancy']}, 'referencesModule': {'references': [{'pmid': '41392942', 'type': 'DERIVED', 'citation': 'Zuniga RM, VanderWalde A, Schwartzberg LS, Spigel DR, Passler L, Hong J, Howland M, Darbonne WC, Szado T, Daniel D. Impact of community recruitment and inclusion initiatives on enrollment in the biomarker-driven MyTACTIC trial. Future Oncol. 2025 Dec 15:1-11. doi: 10.1080/14796694.2025.2595690. Online ahead of print.'}]}, 'descriptionModule': {'briefSummary': 'This is a Phase II, multicenter, non-randomized, open-label, multi-arm study designed to evaluate the safety and efficacy of targeted therapies as single agents or in rational, specified combinations in participants with advanced unresectable or metastatic solid tumors determined to harbor specific biomarkers.\n\nPatients will be enrolled based on local testing performed at a Clinical Laboratory Improvement Amendments (CLIA)-certified or equivalently accredited diagnostic laboratory. The multi-arm structure of the MyTACTIC study allows patients with solid tumors to be treated with a drug or drug regimen tailored to their biomarker identified at screening.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': "Inclusion Criteria:\n\n* Histologically or cytologically confirmed diagnosis of advanced unresectable or metastatic solid malignancy\n* Positive biomarker results from a Clinical Laboratory Improvement Amendments (CLIA)-certified or equivalently accredited diagnostic laboratory and availability of a full report of the testing results. This may be from a tissue or blood sample.\n* Evaluable or measurable disease\n* Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2\n* Life expectancy ≥8 weeks\n* Adequate hematologic and end-organ function, as defined in the protocol, obtained within 14 days prior to initiation of study treatment\n* Agrees to take measures to prevent pregnancy in the patient or partner\n* In addition to the general inclusion criteria above, there are treatment-specific inclusion criteria that apply for each respective treatment arm (as detailed in the protocol)\n\nExclusion Criteria:\n\n* Current participation or enrollment in another therapeutic clinical trial\n* Symptomatic or actively progressing CNS metastases (asymptomatic patients with treated or untreated CNS metastases may be eligible, provided all protocol-defined criteria are met)\n* History of leptomeningeal disease, unless noted otherwise for a specific treatment arm of the study\n* Wide field radiotherapy within 14 days prior to start of study treatment\n* Stereotactic radiosurgery within 7 days prior to start of study treatment\n* Severe infection within 4 weeks prior to initiation of study treatment, including, but not limited to, hospitalization for complications of infections, or any active infection that, in the opinion of the investigator, could impact patient safety\n* Receipt of any anticancer drug/biologic or investigational treatment 21 days prior to Cycle 1, Day 1 except hormone therapy, which can be given up to 7 days prior to Cycle 1, Day 1 (androgen blockage may be continued for male patients with prostate cancer)\n* Known human immunodeficiency virus (HIV), hepatitis C virus (HCV), or hepatitis B virus (HBV) infection with status outside of study-allowed criteria\n* History of or concurrent serious medical condition or abnormality in clinical laboratory tests that precludes the patient's safe participation in and completion of the study or confounds the ability to interpret data from the study\n* History of malignancy other than disease under study within 3 years prior to screening, with the exception of malignancies with a negligible risk of metastasis or death\n* Incomplete recovery from any surgery prior to the start of study treatment that would interfere with the determination of safety or efficacy of study treatment\n* Major surgical procedure, other than for diagnosis, or significant traumatic injury within 4 weeks prior to initiation of study treatment, or anticipation of need for a major surgical procedure during the study\n* Significant cardiovascular disease, such as New York Heart Association cardiac disease (Class II or higher), myocardial infarction, or cerebrovascular accident within 3 months prior to enrollment, unstable arrhythmias, or unstable angina\n* Pregnant or breastfeeding, or intending to become pregnant during the study\n* In addition to the general exclusion criteria above, there are treatment-specific exclusion criteria that apply for each respective treatment arm (as detailed in the protocol)"}, 'identificationModule': {'nctId': 'NCT04632992', 'acronym': 'MyTACTIC', 'briefTitle': 'A Study Evaluating Targeted Therapies in Participants Who Have Advanced Solid Tumors With Genomic Alterations or Protein Expression Patterns Predictive of Response', 'organization': {'class': 'INDUSTRY', 'fullName': 'Genentech, Inc.'}, 'officialTitle': 'MyTACTIC: An Open-Label Phase II Study Evaluating Targeted Therapies in Patients Who Have Advanced Solid Tumors With Genomic Alterations or Protein Expression Patterns Predictive of Response', 'orgStudyIdInfo': {'id': 'ML42439'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Arm A: Entrectinib', 'description': 'Participants in this treatment arm must have a positive tumor biomarker result for ROS1 gene fusion.', 'interventionNames': ['Drug: Entrectinib']}, {'type': 'EXPERIMENTAL', 'label': 'Arm B: Inavolisib', 'description': 'Participants in this treatment arm must have a positive tumor biomarker result for PI3KCA activating mutation.', 'interventionNames': ['Drug: Inavolisib']}, {'type': 'EXPERIMENTAL', 'label': 'Arm C: Alectinib', 'description': 'Participants in this treatment arm must have a positive tumor biomarker result for ALK rearrangement tumors.', 'interventionNames': ['Drug: Alectinib']}, {'type': 'EXPERIMENTAL', 'label': 'Arm D: Ipatasertib', 'description': 'Participants in this treatment arm must have a positive tumor biomarker result for either AKT1/2/3 activating mutation or PTEN loss/loss of function.', 'interventionNames': ['Drug: Ipatasertib']}, {'type': 'EXPERIMENTAL', 'label': "Arm E: Atezolizumab + Investigator's Choice of Chemotherapy", 'description': 'Participants in this treatment arm must have a positive tumor biomarker result for either tumor mutational burden (TMB) high or microsatellite instability (MSI) high/deficient mismatch repair (dMMR).', 'interventionNames': ['Drug: Atezolizumab', "Drug: Investigator's Choice of Chemotherapy"]}, {'type': 'EXPERIMENTAL', 'label': 'Arm F: Trastuzumab Emtansine + Atezolizumab', 'description': 'Participants in this treatment arm must have a positive tumor biomarker result for human epidermal growth factor receptor 2 (HER2) mutations or amplification without known TMB high or MSI high/dMMR.', 'interventionNames': ['Drug: Atezolizumab', 'Drug: Trastuzumab Emtansine']}, {'type': 'EXPERIMENTAL', 'label': 'Arm G: PH FDC SC', 'description': 'Participants in this treatment arm must have a positive tumor biomarker result for HER2 mutation or amplification without known TMB high or MSI high/dMMR.', 'interventionNames': ['Drug: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf']}, {'type': 'EXPERIMENTAL', 'label': "Arm H: PH FDC SC + Investigator's Choice of Chemotherapy", 'description': 'Participants in this treatment arm must have a positive tumor biomarker result for HER2 mutation or amplification without known TMB high or MSI high/dMMR.', 'interventionNames': ['Drug: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf', "Drug: Investigator's Choice of Chemotherapy"]}, {'type': 'EXPERIMENTAL', 'label': 'Arm I: Trastuzumab Emtansine + Tucatinib', 'description': 'Participants in this treatment arm must have a positive tumor biomarker result for HER2 mutation or amplification without known TMB high or MSI high/dMMR.', 'interventionNames': ['Drug: Trastuzumab Emtansine', 'Drug: Tucatinib']}, {'type': 'EXPERIMENTAL', 'label': 'Arm J: Trastuzumab Emtansine + Atezolizumab', 'description': 'Participants in this treatment arm must have positive tumor biomarker results for HER2 mutation or amplification and TMB high or MSI high/dMMR.', 'interventionNames': ['Drug: Atezolizumab', 'Drug: Trastuzumab Emtansine']}, {'type': 'EXPERIMENTAL', 'label': 'Arm K: Ipatasertib + Atezolizumab', 'description': 'Participants in this treatment arm must have a positive tumor biomarker result for PI3KCA activating mutation.', 'interventionNames': ['Drug: Ipatasertib', 'Drug: Atezolizumab']}, {'type': 'EXPERIMENTAL', 'label': 'Arm L: Ipatasertib + Atezolizumab', 'description': 'Participants in this treatment arm must have a positive tumor biomarker result for either AKT1/2/3 activating mutation or PTEN loss/loss of function.', 'interventionNames': ['Drug: Ipatasertib', 'Drug: Atezolizumab']}, {'type': 'EXPERIMENTAL', 'label': 'Arm M: Ipatasertib + Paclitaxel', 'description': 'Participants in this treatment arm must have a positive tumor biomarker results for PI3KCA activating mutations and either AKT1/2/3 activating mutation or PTEN loss/loss of function.', 'interventionNames': ['Drug: Ipatasertib', 'Drug: Paclitaxel']}, {'type': 'EXPERIMENTAL', 'label': 'Arm N: Atezolizumab + Tiragolumab', 'description': 'Participants in this treatment arm must have a positive tumor biomarker result for either TMB high or MSI high/dMMR.', 'interventionNames': ['Drug: Atezolizumab', 'Drug: Tiragolumab']}, {'type': 'EXPERIMENTAL', 'label': 'Arm O: Pralsetinib', 'description': 'Participants in this treatment arm must have a positive tumor biomarker result for RET fusion.', 'interventionNames': ['Drug: Pralsetinib']}], 'interventions': [{'name': 'Entrectinib', 'type': 'DRUG', 'otherNames': ['Rozlytrek™', 'RG6268', 'RO7102122'], 'description': 'Entrectinib will be self-administered by participants orally at home (except on clinic days), at the same time each day, on a starting dose of 600 milligrams (mg) per day once a day (QD) until disease progression, intolerable toxicity, or consent withdrawal.', 'armGroupLabels': ['Arm A: Entrectinib']}, {'name': 'Inavolisib', 'type': 'DRUG', 'otherNames': ['GDC-0077', 'RG6114', 'RO7113755'], 'description': 'Inavolisib will be self-administered by participants orally at home (except on clinic days) at the same time each day, on a starting dose of 9 mg/day QD until disease progression, intolerable toxicity, or consent withdrawal.', 'armGroupLabels': ['Arm B: Inavolisib']}, {'name': 'Alectinib', 'type': 'DRUG', 'otherNames': ['Alecensa®', 'RG7853', 'RO5424802'], 'description': 'Alectinib will be self-administered by participants orally at home (except on clinic days), at the same times each day, on a starting dose of 600 mg twice a day (BID) until disease progression, intolerable toxicity, or consent withdrawal.', 'armGroupLabels': ['Arm C: Alectinib']}, {'name': 'Ipatasertib', 'type': 'DRUG', 'otherNames': ['GDC-0068', 'RG7440', 'RO5532961'], 'description': 'Ipatasertib will be self-administered by participants orally at home (except on clinic days), at the same time each day, on a starting dose of 400 mg QD until disease progression, intolerable toxicity, or consent withdrawal.', 'armGroupLabels': ['Arm D: Ipatasertib', 'Arm K: Ipatasertib + Atezolizumab', 'Arm L: Ipatasertib + Atezolizumab', 'Arm M: Ipatasertib + Paclitaxel']}, {'name': 'Atezolizumab', 'type': 'DRUG', 'otherNames': ['Tecentriq®', 'RG7446', 'RO5541267'], 'description': 'Atezolizumab will be administered by intravenous (IV) infusion at a fixed dose of 1200 mg for participants on Day 1 of each 21-day cycle until unacceptable toxicity or progressive disease (or loss of clinical benefit).', 'armGroupLabels': ["Arm E: Atezolizumab + Investigator's Choice of Chemotherapy", 'Arm F: Trastuzumab Emtansine + Atezolizumab', 'Arm J: Trastuzumab Emtansine + Atezolizumab', 'Arm K: Ipatasertib + Atezolizumab', 'Arm L: Ipatasertib + Atezolizumab', 'Arm N: Atezolizumab + Tiragolumab']}, {'name': 'Trastuzumab Emtansine', 'type': 'DRUG', 'otherNames': ['Kadcyla®', 'RG3502', 'RO5304020'], 'description': 'Trastuzumab emtansine will be administered at 3.6 mg per kilogram (kg) of body weight by IV infusion every 21 days (unless dose reduction and/or dose delays are required) until disease progression or unacceptable toxicity.', 'armGroupLabels': ['Arm F: Trastuzumab Emtansine + Atezolizumab', 'Arm I: Trastuzumab Emtansine + Tucatinib', 'Arm J: Trastuzumab Emtansine + Atezolizumab']}, {'name': 'Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf', 'type': 'DRUG', 'otherNames': ['PHESGO™', 'PH FDC SC', 'Fixed dose combination of trastuzumab and pertuzumab administered subcutaneously', 'RG6264', 'RO7198574'], 'description': 'PH FDC SC will be administered subcutaneously (SC) at a fixed non-weight-based dose. A loading dose of 1200 mg SC pertuzumab and 600 mg SC trastuzumab is then followed by a maintenance dose of 600 mg SC pertuzumab and 600 mg SC trastuzumab once every 3 weeks.', 'armGroupLabels': ['Arm G: PH FDC SC', "Arm H: PH FDC SC + Investigator's Choice of Chemotherapy"]}, {'name': 'Tucatinib', 'type': 'DRUG', 'otherNames': ['Tukysa™'], 'description': 'Tucatinib 300 mg will be administered orally BID continuously starting from Cycle 1 Day 1 onwards.', 'armGroupLabels': ['Arm I: Trastuzumab Emtansine + Tucatinib']}, {'name': "Investigator's Choice of Chemotherapy", 'type': 'DRUG', 'description': 'Chemotherapy will consist of docetaxel, paclitaxel, or capecitabine, as determined by the investigator, and will be administered per the respective package insert and institutional guidelines.', 'armGroupLabels': ["Arm E: Atezolizumab + Investigator's Choice of Chemotherapy", "Arm H: PH FDC SC + Investigator's Choice of Chemotherapy"]}, {'name': 'Paclitaxel', 'type': 'DRUG', 'description': 'The dose of paclitaxel is 80 mg/m2 administered by IV infusion on Days 1, 8, and 15 of each 28-day cycle. The paclitaxel infusion will be delivered over at least 60 minutes for each dose per institutional guidelines and administered after the oral dose of ipatasertib.', 'armGroupLabels': ['Arm M: Ipatasertib + Paclitaxel']}, {'name': 'Tiragolumab', 'type': 'DRUG', 'otherNames': ['RG6058', 'RO7092284', 'MTIG7192A'], 'description': 'Following the administration of atezolizumab and an observation period, participants will receive 600 mg tiragolumab at a fixed dose administered by IV infusion on Day 1 of each 21-day cycle.', 'armGroupLabels': ['Arm N: Atezolizumab + Tiragolumab']}, {'name': 'Pralsetinib', 'type': 'DRUG', 'otherNames': ['GAVRETO™', 'RG6396', 'RO7499790'], 'description': 'Pralsetinib will be self-administered by participants orally at home (except on clinic days), at the same time each day, on a starting dose of 400 mg/day (four 100-mg capsules per day) once a day (QD) until disease progression, intolerable toxicity, or consent withdrawal.', 'armGroupLabels': ['Arm O: Pralsetinib']}]}, 'contactsLocationsModule': {'locations': [{'zip': '99508', 'city': 'Anchorage', 'state': 'Alaska', 'country': 'United States', 'facility': 'Alaska Oncology and Hematology', 'geoPoint': {'lat': 61.21806, 'lon': -149.90028}}, {'zip': '85755-6216', 'city': 'Oro Valley', 'state': 'Arizona', 'country': 'United States', 'facility': 'Arizona Clinical Research Ctr', 'geoPoint': {'lat': 32.39091, 'lon': -110.96649}}, {'zip': '71913', 'city': 'Hot Springs', 'state': 'Arkansas', 'country': 'United States', 'facility': 'Genesis Cancer Center', 'geoPoint': {'lat': 34.5037, 'lon': -93.05518}}, {'zip': '92024-1328', 'city': 'Encinitas', 'state': 'California', 'country': 'United States', 'facility': 'California Cancer Associates for Research and Excellence - Encinitas', 'geoPoint': {'lat': 33.03699, 'lon': -117.29198}}, {'zip': '90017', 'city': 'Los Angeles', 'state': 'California', 'country': 'United States', 'facility': 'Los Angeles Hematology Oncology Medical Group', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '93940', 'city': 'Monterey', 'state': 'California', 'country': 'United States', 'facility': 'Pacific Cancer Care - Monterey', 'geoPoint': {'lat': 36.60024, 'lon': -121.89468}}, {'zip': '94118', 'city': 'San Francisco', 'state': 'California', 'country': 'United States', 'facility': 'Kaiser Permanente - San Francisco Medical Center', 'geoPoint': {'lat': 37.77493, 'lon': -122.41942}}, {'zip': '90403', 'city': 'Santa Monica', 'state': 'California', 'country': 'United States', 'facility': 'Sarcoma Oncology Center', 'geoPoint': {'lat': 34.01949, 'lon': -118.49138}}, {'zip': '94589', 'city': 'Vallejo', 'state': 'California', 'country': 'United States', 'facility': 'Kaiser Permanente Medical Ctr', 'geoPoint': {'lat': 38.10409, 'lon': -122.25664}}, {'zip': '93003', 'city': 'Ventura', 'state': 'California', 'country': 'United States', 'facility': 'Ventura County Hematology Oncology Specialists', 'geoPoint': {'lat': 34.27834, 'lon': -119.29317}}, {'zip': '06360-2740', 'city': 'Norwich', 'state': 'Connecticut', 'country': 'United States', 'facility': 'Eastern CT Hematology and Oncology Associates', 'geoPoint': {'lat': 41.52426, 'lon': -72.07591}}, {'zip': '33916', 'city': 'Fort Myers', 'state': 'Florida', 'country': 'United States', 'facility': 'SCRI Florida Cancer Specialists South', 'geoPoint': {'lat': 26.62168, 'lon': -81.84059}}, {'zip': '33705-1400', 'city': 'St. Petersburg', 'state': 'Florida', 'country': 'United States', 'facility': 'Florida Cancer Specialists - NORTH - SCRI - PPDS', 'geoPoint': {'lat': 27.77086, 'lon': -82.67927}}, {'zip': '32308', 'city': 'Tallahassee', 'state': 'Florida', 'country': 'United States', 'facility': 'Florida Cancer Specialists - PAN - SCRI - PPDS', 'geoPoint': {'lat': 30.43826, 'lon': -84.28073}}, {'zip': '33401-3406', 'city': 'West Palm Beach', 'state': 'Florida', 'country': 'United States', 'facility': 'Florida Cancer Specialists - EAST - SCRI - PPDS', 'geoPoint': {'lat': 26.71534, 'lon': -80.05337}}, {'zip': '83712', 'city': 'Boise', 'state': 'Idaho', 'country': 'United States', 'facility': 'St Luke?s Cancer Institute', 'geoPoint': {'lat': 43.6135, 'lon': -116.20345}}, {'zip': '70809', 'city': 'Baton Rouge', 'state': 'Louisiana', 'country': 'United States', 'facility': 'Hematology and Oncology Clinic', 'geoPoint': {'lat': 30.44332, 'lon': -91.18747}}, {'zip': '21229-5201', 'city': 'Baltimore', 'state': 'Maryland', 'country': 'United States', 'facility': 'Saint Agnes Hospital - Baltimore - Hunt - PPDS', 'geoPoint': {'lat': 39.29038, 'lon': -76.61219}}, {'zip': '48236', 'city': 'Detroit', 'state': 'Michigan', 'country': 'United States', 'facility': 'Ascension St. John Hospital', 'geoPoint': {'lat': 42.33143, 'lon': -83.04575}}, {'zip': '59102', 'city': 'Billings', 'state': 'Montana', 'country': 'United States', 'facility': 'Frontier Cancer Center and Blood Institute', 'geoPoint': {'lat': 45.78329, 'lon': -108.50069}}, {'zip': '68510-2496', 'city': 'Lincoln', 'state': 'Nebraska', 'country': 'United States', 'facility': 'Southeast Nebraska Cancer Center', 'geoPoint': {'lat': 40.8, 'lon': -96.66696}}, {'zip': '08724-3009', 'city': 'Brick', 'state': 'New Jersey', 'country': 'United States', 'facility': 'New Jersey Hematology Oncology Associates LLC', 'geoPoint': {'lat': 40.05928, 'lon': -74.13708}}, {'zip': '08816', 'city': 'East Brunswick', 'state': 'New Jersey', 'country': 'United States', 'facility': 'Astera Cancer Care East Brunswick', 'geoPoint': {'lat': 40.42788, 'lon': -74.41598}}, {'zip': '10028-0506', 'city': 'New York', 'state': 'New York', 'country': 'United States', 'facility': 'Central Park Hematology and Oncology', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'zip': '10469', 'city': 'The Bronx', 'state': 'New York', 'country': 'United States', 'facility': 'Eastchester Center for Cancer Care', 'geoPoint': {'lat': 40.84985, 'lon': -73.86641}}, {'zip': '10469', 'city': 'The Bronx', 'state': 'New York', 'country': 'United States', 'facility': 'New York Cancer & Blood Specialists', 'geoPoint': {'lat': 40.84985, 'lon': -73.86641}}, {'zip': '28806', 'city': 'Asheville', 'state': 'North Carolina', 'country': 'United States', 'facility': 'Messino Cancer Centers', 'geoPoint': {'lat': 35.60095, 'lon': -82.55402}}, {'zip': '44718', 'city': 'Canton', 'state': 'Ohio', 'country': 'United States', 'facility': 'Gabrail Cancer Center', 'geoPoint': {'lat': 40.79895, 'lon': -81.37845}}, {'zip': '44718', 'city': 'Canton', 'state': 'Ohio', 'country': 'United States', 'facility': 'Tri County Hematologyoncology', 'geoPoint': {'lat': 40.79895, 'lon': -81.37845}}, {'zip': '43219', 'city': 'Columbus', 'state': 'Ohio', 'country': 'United States', 'facility': 'SCRI Mark H. Zangmeister Center', 'geoPoint': {'lat': 39.96118, 'lon': -82.99879}}, {'zip': '97227', 'city': 'Portland', 'state': 'Oregon', 'country': 'United States', 'facility': 'Kaiser Permanente Center For Health Research', 'geoPoint': {'lat': 45.52345, 'lon': -122.67621}}, {'zip': '37404', 'city': 'Chattanooga', 'state': 'Tennessee', 'country': 'United States', 'facility': 'Sarah Cannon Research Institute / Tennessee Oncology', 'geoPoint': {'lat': 35.04563, 'lon': -85.30968}}, {'zip': '38138', 'city': 'Memphis', 'state': 'Tennessee', 'country': 'United States', 'facility': 'The West Clinic, PC dba West Cancer Center', 'geoPoint': {'lat': 35.14953, 'lon': -90.04898}}, {'zip': '37203', 'city': 'Nashville', 'state': 'Tennessee', 'country': 'United States', 'facility': 'SCRI Oncology Partners', 'geoPoint': {'lat': 36.16589, 'lon': -86.78444}}, {'zip': '76104-4611', 'city': 'Fort Worth', 'state': 'Texas', 'country': 'United States', 'facility': 'The Center for Cancer and Blood Disorders - PPDS', 'geoPoint': {'lat': 32.72541, 'lon': -97.32085}}, {'zip': '78229', 'city': 'San Antonio', 'state': 'Texas', 'country': 'United States', 'facility': 'Mays Cancer Center at UT Health San Antonio MD Anderson Cancer', 'geoPoint': {'lat': 29.42412, 'lon': -98.49363}}, {'zip': '23219', 'city': 'Richmond', 'state': 'Virginia', 'country': 'United States', 'facility': 'Virginia Commonwealth University - Massey Cancer Center', 'geoPoint': {'lat': 37.55376, 'lon': -77.46026}}, {'zip': '98003', 'city': 'Federal Way', 'state': 'Washington', 'country': 'United States', 'facility': 'Northwest Medical Specialties B', 'geoPoint': {'lat': 47.32232, 'lon': -122.31262}}], 'overallOfficials': [{'name': 'Clinical Trials', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Genentech, Inc.'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'YES', 'description': "For eligible studies, qualified researchers may request access to individual patient level clinical data. See Roche's commitment to transparency of clinical study information here: https://go.roche.com/data\\_sharing"}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Genentech, Inc.', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}